2004-07-02 12:00:56 |
Disclosure Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3efb8aaa851be2355a02be0402b9e885 |
|
2004-07-28 14:09:07 |
Supplementary Disclosure Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9471df49c428525ecb0ca062370e0645 |
|
2004-08-31 11:45:42 |
Admission to Official List |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b10f1c6157480b454c0b875781713c3 |
Admission to Official List
|
2004-08-31 11:47:42 |
Pre-Quotation Disclosure |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22bca08096078816960e44b4d758d5fc |
Stock Exchange Announcement - Other
|
2004-08-31 11:48:42 |
Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61578e49b259c29d8c28da3796f7f2c5 |
|
2004-08-31 11:48:42 |
Circular re: Commencement of Official Quotation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da24a50949f99ab04d4e3ba46562dc3e |
Commencement of Official Quotation
|
2004-08-31 11:49:45 |
Top 20 shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9c08bbc3321c578e774495bbab47c50 |
|
2004-08-31 11:50:45 |
Statement of Escrow Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68ee167ca0234fe6f0e58edb7eca6ebc |
|
2004-08-31 11:51:47 |
Consolidated Proforma Statement of Financial Position |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65dfcf19cb622a8385d258a170f5ffb4 |
|
2004-08-31 11:53:47 |
Updated Statement of Commitment of Funds Raised |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2973f09f577ca8699b0612f79a727f2e |
|
2004-08-31 11:55:49 |
Statement of the status of Convertible Notes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9d97535ca103295d8b9c0c9a8ab678e |
|
2004-08-31 11:56:49 |
Statement that coy has formally applied to delist from NSX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5851801fd1bce5f19829578d39f5c9b5 |
Company Administration - Other
|
2004-08-31 12:14:05 |
Terms & Conditions for Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cbb76b40ef8c8fcdf8f94dbd9893110 |
|
2004-08-31 12:18:14 |
Appendix 1A - Application for admission to the official list |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c45b9b46c7f3a4219442c88131e21ab |
Company Administration - Other
|
2004-08-31 12:52:46 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ad6031cf3bab99321ea8d9273c8372b |
|
2004-08-31 12:59:55 |
Preliminary Final Report - 17/03/03 to 30/06/04 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a12733b049220d1f16102047defe97b |
|
2004-09-06 12:28:27 |
Initial Director's Interest Notice x5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d746761b0d4a8d3d3f6b3034ce64eb5 |
Initial Director's Interest Notice
|
2004-09-06 16:09:08 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/787bd393a4a36f5140b3037ae0b0d15a |
Change in substantial holding
|
2004-09-07 15:52:48 |
Diabetes treatment successful in pre-clinical trials |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4691f0d7da01217e718b05a144011000 |
|
2004-09-07 15:56:53 |
Scientists rep successful cell implantation at intl meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ef81db70e7b01fa73e1b689dac305f9 |
|
2004-09-07 16:08:05 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f63698ddfdddf64421775b3510c750a |
Change of Director's Interest Notice
|
2004-09-17 17:32:31 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/710cdd742e59a9dbe3e4fd379aa45479 |
Becoming a substantial holder
|
2004-09-20 15:27:25 |
Expiration of Restriction Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c7911faa457c0b44dc7d84f09ebde77 |
|
2004-09-27 14:09:07 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a564df08726aa74051b834c993eb8e68 |
Notice of Annual General Meeting
|
2004-10-01 10:11:07 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e9cd4340afc7e796d059fc2a2e274cc |
Full Year Directors' Statement
Full Year Directors' Report
|
2004-10-11 10:50:43 |
LCT Treatment Protects the Brain from Damage by Huntington's |
1 |
https://app.sharelinktechnologies.com/announcement/asx/64320a741719510071c4332eb07d1604 |
|
2004-10-11 12:21:19 |
Appendix 3B - Release of Securities from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62d23d6361d893bcb00b17e87c98567e |
|
2004-10-12 12:24:18 |
Placement to extend R & D including Huntingtons disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5071ab071b5b69f56857a1b09174780 |
|
2004-10-27 12:13:08 |
Completes Treatment Phase of Pre-Clinical Study -Diabetes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbebc0a8016c9e2cd1ad660e54ebf1d5 |
|
2004-10-28 10:36:33 |
Chairman's Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6991163597b491d5c7165352124796e7 |
Chairman's Address to Shareholders
|
2004-10-29 16:08:04 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/523eb6c33e9ee2a32ec6f75d8f0639d6 |
|
2004-10-29 16:44:35 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d1742603ced669ed7b8e95328403928 |
Commitments Test Entity - First Quarter Report
|
2004-10-29 16:59:56 |
Change of Registered Address & Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75003463f8e84b58bb3457ba4e7df175 |
Details of Company Address
Company Secretary Appointment/Resignation
|
2004-11-03 15:17:15 |
Placement confirmation details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a114eb677cc0eeb2e283c27d986cb25 |
|
2004-11-03 15:19:17 |
Appendix 3B: Funds for Working Capital |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d6ffe4e855255ddd3e76d1b5f4b181f |
|
2004-11-03 15:21:19 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/201b18fc160d18888ac7b6dc372a00ee |
|
2004-11-03 15:23:21 |
Appendix 3B-exercise of A Class Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bb9503923e829878bec41008df68f1a |
|
2004-11-04 12:12:09 |
Long-term safety of transplanted pig cells to humans confirm |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff9a5148333dbf73e5da68b6a198e621 |
|
2004-11-15 14:35:33 |
Appendix 3B - Conversion of C Class Note |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b269271196a0860a59948e5fc65d429 |
|
2004-11-15 14:38:35 |
Appendix 3B - Directors & Employees Option Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/baaa7ebf43bf2c13ff6bde0f200f2ee7 |
|
2004-11-22 09:24:22 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55bd65e02d4b51b45e56aae495db0b34 |
Initial Director's Interest Notice
|
2004-11-22 09:25:24 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2292223018d89c6bf72341dd82bb039c |
Change of Director's Interest Notice
|
2004-11-22 09:27:25 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e101c60f96fcd53f1ef5b0996975d4e6 |
Change of Director's Interest Notice
|
2004-11-22 13:22:20 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ba6e877e517b129d661f92b45def41f |
Change in substantial holding
|
2004-11-29 14:48:46 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a650c478a6e7ab21aa4d1b602024720d |
Change of Director's Interest Notice
|
2004-11-29 15:09:54 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32dbaf82cf1a7b42132e35e55cc01fcb |
Change in substantial holding
|
2004-11-29 15:11:08 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c69d5f4d839647e0b89d184f2539fc45 |
Change in substantial holding
|
2004-12-03 15:50:48 |
Appendix 3B - Service Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a6ce4e280be51899ce5b47f41a98512 |
|
2004-12-15 15:14:11 |
Message from the Chairman of LCT : Mr Michael Yates |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3225b1716cddedd6854d28b6eafeebc5 |
Company Administration - Other
Letter to Shareholders - Other
|
2004-12-24 10:40:39 |
Release from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46b7a60fb987580371318c05a2400aaf |
|
2005-01-18 10:15:14 |
Newsletter January 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd10b03b987885f18a3e061ff34ea858 |
|
2005-01-28 14:49:47 |
Appendix 3B: Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28252bcc9d6010e7f9cf13054b39b08e |
|
2005-01-28 14:52:45 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd1432b198821eb5440e5130a5269101 |
Commitments Test Entity - Second Quarter Report
|
2005-01-31 14:31:29 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/713a130b9e85d470c9e9419cc2501b11 |
Company Secretary Appointment/Resignation
|
2005-02-24 10:14:03 |
LCT achieves successful use of it DiaBCell Product |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef14bfb36429759c2c135fffacfc5954 |
|
2005-02-28 16:42:37 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55edef32d4b759ffacd4307e3070f9a7 |
Half Year Directors' Statement
Half Year Directors' Report
|
2005-03-03 10:04:56 |
Acquires US$90m of Developed Cell Therapy Products |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a4086c40c3aa4cd243fb92cb854fec8 |
|
2005-03-10 12:49:47 |
Appoints General Manager |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6949c51a7d893415f0da483ede46c2f4 |
Company Administration - Other
|
2005-03-14 16:43:42 |
Release from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2ba02e211ff5c9637b94c1cc145dd1d |
|
2005-03-18 15:58:56 |
Appendix 3B: End of restriction period |
0 |
https://app.sharelinktechnologies.com/announcement/asx/377baae193c0ab9175bca51124c81c68 |
|
2005-03-18 16:03:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bfc90a9c16380510ece4d94036a20c2 |
|
2005-04-05 14:27:21 |
LCT Successfuly Completes Preclinical Diabetes Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/24033e36f2655839fcba6a8dd9032e2c |
|
2005-04-06 16:07:05 |
9-Year survival of transplanted pig islet cells in Diabetic |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8d37f58a1ed47e3ec0828c173718aea |
|
2005-04-26 14:24:22 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4003fa0202d097bdf5357ef76448291b |
Notice of Extraordinary General Meeting
|
2005-04-26 14:27:25 |
Quarterly Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd5e256929fc5a6e83d48a6b7374feec |
Letter to Shareholders - Other
|
2005-04-27 11:52:48 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd89aac08f9bbfadd357532af12514fc |
Commitments Test Entity - Third Quarter Report
|
2005-04-29 12:40:39 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b619dfbfedb5ccf5125e9423b20c89e |
Change of Director's Interest Notice
|
2005-05-25 15:37:35 |
General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad5184e5643e08787ab78ac1ead34bec |
Notice of Meeting - Other
|
2005-05-25 15:41:39 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/caa24205fa29ebe7d3c7367754ffceb2 |
|
2005-05-31 08:43:41 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/762a74d91c56edbcc1c14053127fc0f5 |
Change of Director's Interest Notice
|
2005-07-20 10:08:06 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2223965623805cbef1cf81f79ab0f4a |
|
2005-07-29 16:14:06 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6d27bd0b3b7260090f15045d8e87847 |
Commitments Test Entity - Fourth Quarter Report
|
2005-08-01 13:35:34 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb0347ef4e2e7bf844139b7cc65c3f40 |
Change of Director's Interest Notice
|
2005-08-01 13:38:37 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5077efc42b1363d972237d4d9ce9e7f |
Change of Director's Interest Notice
|
2005-08-02 08:41:38 |
Pre-Clinical results for treating Huntingtons Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eedbd8d314d046a13c9c290c684b73fb |
|
2005-08-05 11:34:30 |
The Quarterly Newsletter from Living Cell Technologies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bc0de2ed69d3cccb3860b58c39582c0 |
|
2005-08-09 09:33:31 |
LCT raises $2.3 million in placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/062bea559ff45d2eb9f8cb61fb20aecb |
|
2005-08-22 14:15:13 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99776e1720f6c9949988bc8ecd5f2910 |
|
2005-08-23 17:14:11 |
Becoming a substantial holder from AXA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3b52450efe89e2ce2be9d16b16a6553 |
Becoming a substantial holder
|
2005-09-02 16:26:23 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc56f6925d2af1e0a42bd7cca2e0759f |
Change of Director's Interest Notice
|
2005-09-13 12:34:30 |
Preliminary Final Report & Full Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f15080863fab063a6c4c8ba1914905fe |
Full Year Directors' Statement
Full Year Directors' Report
|
2005-09-21 10:51:50 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42dfe5c2e420de4bd04a06873d31f6ac |
|
2005-09-29 15:12:11 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/056fc9054abe0f9d42a8bf3960a473e9 |
Change of Director's Interest Notice
|
2005-10-04 10:59:55 |
LCT & MultiCell announce Joint Venture |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e769e660fa4dc3849febb8ddd7088dd |
|
2005-10-12 10:25:22 |
US Neuroscientist appointed Chief Scientific Officer of LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/621d11b217b220ceaf7ae906c27c099f |
Company Administration - Other
|
2005-10-18 14:35:33 |
Notice of AGM & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13cbafc2987b869a75e91f86dee23f52 |
Notice of Annual General Meeting
|
2005-10-18 14:36:32 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad0dcf1fed97222c09de736f0ad56d97 |
Full Year Directors' Statement
Full Year Directors' Report
|
2005-10-20 11:08:02 |
Files Pre-IND Request Letter with FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b43ebad09f6c860d28ebf3983e699cf |
|
2005-10-21 15:47:42 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5ba9781c4f7292e46d6966cb477280c |
Change of Director's Interest Notice
|
2005-10-26 09:24:21 |
Quarterly Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76539ae452872554118cb6862aaf27d3 |
|
2005-10-27 16:38:35 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ef930472e08d7bff13c46dcab15bdba |
Commitments Test Entity - First Quarter Report
|
2005-11-16 15:43:39 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a53ec7d301b39c7bcd611f73dad581a |
Chairman's Address to Shareholders
|
2005-11-16 17:26:21 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7a62408dc641a9c078e6d426c4bbc49 |
|
2005-12-08 09:41:39 |
To meet with the US Food & Drug Administration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b02e5a4c9c9ba5422894c9001e9bd632 |
|
2005-12-14 10:29:23 |
Cell Therapy Supported Through Bioethics Recommendation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/def845ee9e5cb7d2d45e9d9cd0f5bb55 |
|
2005-12-15 14:29:27 |
Release from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f509cfd7073c2f526c60cc112f1e988 |
|
2005-12-21 11:09:04 |
Awarded grant by NZTE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b3002aa367ce2052c6bd17cd8b8afdf |
|
2005-12-22 10:14:10 |
Awarded $100 000 grant by Cure Kids New Zealand |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1182f5e008e3e35db2499aba66b437f |
|
2006-01-11 10:06:05 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57b6d7f471234f99393d636aea63aef0 |
|
2006-01-11 10:15:09 |
Raises additional funds from US Investors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d3cc56aa65ba0dbf17353b4ba15c5d5 |
|
2006-01-23 09:55:54 |
Notice of General Meeting/Proxy Form & Explanatory Memo. |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9482be147b3ff80f818b638325f4783a |
Notice of General Meeting
|
2006-01-23 10:01:58 |
Set to raise additional US & European capital |
1 |
https://app.sharelinktechnologies.com/announcement/asx/910381b0d0b4aa6b586381c48db2bdbd |
|
2006-01-31 11:13:10 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ff24c0d4843e2815eab5e196f9404e1 |
Commitments Test Entity - Second Quarter Report
|
2006-02-07 10:41:39 |
A Quarterly Newsletter from Living Cell Technologies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa627e4a68e57a8cece7b907912b1384 |
Letter to Shareholders - Other
|
2006-02-09 15:11:09 |
Ceasing to be a substantial holder from AXA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97345439e2aef51521e5c2f69963ba38 |
Ceasing to be a substantial holder
|
2006-02-16 12:36:30 |
Reports Positive Meetings with FDA/MedSafe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce460b6bcb8381cb016f10c394d52169 |
|
2006-02-21 10:12:09 |
Biocapsule reviewed in international journal Biomaterials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/524e2d07bbab0701d33a84381d8f7db5 |
|
2006-02-24 08:48:46 |
Appointment of Charles Macek |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c523fd9eadff4e44a58483d547419f96 |
Director Appointment/Resignation
|
2006-02-24 14:52:48 |
Presentation to General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5984c6028e6601d6cfdd40d059c2c2c |
Chairman's Address to Shareholders
|
2006-02-24 16:36:34 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cba7b78a5eeeff64d17785e8c169a1d1 |
|
2006-03-07 09:56:51 |
LCT & The Bionic Ear Institute announce Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3db8345871c6ef33aef4d063b3e39e69 |
|
2006-03-16 16:37:34 |
Half Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1469eabb9e93612f9892a5d9344ac01b |
Half Year Directors' Statement
Half Year Directors' Report
|
2006-03-16 17:15:13 |
Half Yearly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f86a268969b303a553b7c649f7f8ae7e |
|
2006-03-16 17:16:02 |
Half Yearly Report Period Ended 31/12/05 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50e2d514e2bef5e9af582b9953718f1e |
|
2006-03-23 15:36:33 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/588958e19f272f172560094f51067769 |
Change of Director's Interest Notice
|
2006-03-23 17:06:04 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72401ce714ff0d50bcef72e95ac88d07 |
Initial Director's Interest Notice
|
2006-03-27 14:49:48 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7371c56b5ae39e4d60a49689eab6b451 |
Final Director's Interest Notice
|
2006-04-11 11:22:21 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/251465a320c219a962e222f3984eaaad |
Change of Director's Interest Notice
|
2006-04-26 10:01:56 |
Awarded NZ$2.7m Investment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30a8cebe98304bcf541054a208af5576 |
|
2006-04-28 13:39:36 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/595834e24c81e9ad0e4820804125aa08 |
Commitments Test Entity - Third Quarter Report
|
2006-05-02 10:02:00 |
Quarterly Newsletter from Living Cell Technologies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35b4f9d56656bddae92ac3cb8b1bf9d0 |
|
2006-05-15 15:26:25 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9b188db2ac3b8e3fde173d4e8855363 |
Change of Director's Interest Notice
|
2006-05-22 10:32:28 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9f2c4cc411d71f2241c334bfe087ed4 |
Change of Director's Interest Notice
|
2006-05-31 11:36:34 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a949f1d953a33300075e6a7e686306ae |
Change of Director's Interest Notice
|
2006-05-31 12:58:56 |
Amended Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/482e2413e03ffb69f8d0a27c8c0ab512 |
Change of Director's Interest Notice
|
2006-06-01 11:45:39 |
Response to enquire re: Director Shareholdings |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a934b4f32d776630c8abee8c7b25ea18 |
Security holder details - Other
|
2006-06-30 13:15:14 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb5d0d75c55cbcb6425620bc8ae46a0b |
|
2006-07-05 09:38:34 |
Granted Diabetes Patent in the US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c6cb45e11b86ab16af155a5dbaf6047 |
|
2006-07-07 13:02:58 |
Raises $2.8M in Fund Transaction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3abd04f51631f1e86b36df6c41d8dbc5 |
|
2006-07-27 09:40:35 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/18aa477b311c0472d21a6bd8def58dce |
Commitments Test Entity - Fourth Quarter Report
|
2006-07-31 10:44:42 |
August Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/003ddc85b67e39fd059cd58cf63679dd |
|
2006-08-08 15:14:13 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f00d71a1243173f4b53622a2b9e2bbd8 |
|
2006-08-15 09:29:26 |
To present at Royal Society of New Zealand meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e3be86808dc454263b3fc6864b608cf |
|
2006-08-17 13:34:32 |
Release from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae9b5b398d63841be4eb33b002239dd5 |
|
2006-08-17 13:38:37 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/772f4fdb6285f2127a2bdf2f908f1927 |
|
2006-08-24 09:48:45 |
Lodges application for clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f6b39ddf937fb3c9805383e6c01c09d |
|
2006-08-25 10:52:51 |
New Chairman & Additional Independent Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7123bd682fcac2ac6ae5b6aa7fb70e03 |
Director Appointment/Resignation
Company Administration - Other
|
2006-08-29 09:42:40 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/989b162d0080bf0a43a5a447c1b6f318 |
Final Director's Interest Notice
|
2006-08-31 15:24:23 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6311c15056009f3896fa6a14f56a04ee |
|
2006-08-31 15:36:35 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47e4fd3722b7a7e4c59e6fe591b87810 |
Initial Director's Interest Notice
|
2006-09-13 16:46:43 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53300c736adee3a49f33d8a899ff8e0e |
Full Year Directors' Report
|
2006-09-18 13:53:51 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e494320c4843aa815261605fe97635a |
|
2006-09-22 11:43:41 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48fff2b81edb32082c575b987a6129ea |
Change of Director's Interest Notice
|
2006-09-29 15:34:15 |
Audited Financial Statements |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35faa8aa0b40645110c33e09f96e4332 |
Full Year Directors' Statement
Full Year Directors' Report
|
2006-10-05 17:12:11 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7b4f310d5b1e4fd807e2756d120dd59 |
Notice of General Meeting
|
2006-10-19 09:40:37 |
Granted Diabetes Patent Across the EU |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13d0d2b467e7bba36d145f86d5327a71 |
|
2006-10-25 09:42:40 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cc76b50caaa5bc437236adb841fc149 |
Notice of Annual General Meeting
|
2006-10-25 09:53:49 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a50e47eee43617fb40675849a0e03a63 |
Full Year Directors' Statement
Full Year Directors' Report
|
2006-10-31 15:59:53 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53788a2e766fbdbbc0578e18bae941c6 |
Commitments Test Entity - First Quarter Report
|
2006-11-01 09:46:42 |
November Newsletter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a60037dd11fbbb46724974ef0bce31c |
|
2006-11-06 15:35:33 |
General Meeting Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b12b9ffccbda300eb914bc824baaa0d |
|
2006-11-21 14:42:41 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0065652990d76c251cd80aa25e94925 |
Change of Director's Interest Notice
|
2006-11-24 12:07:01 |
Progress on Funding Initiatives |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3dcc0bb216ce2af92957e5aa60a4a0e |
|
2006-11-24 13:27:24 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2bd5e777b22243a83c8e472609826d2 |
Chairman's Address - Other
|
2006-11-24 14:54:51 |
Annual General Meeting Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/445d08437b267bb5d250cb47686f8ffd |
|
2006-11-30 13:19:18 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/863ccf90a130407f42c19125720a97f2 |
Change of Director's Interest Notice
|
2006-12-07 08:50:49 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f76557c9f30c202673e647111b869e9d |
Change of Director's Interest Notice
|
2006-12-07 11:25:23 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7eabfc04c6ec3b70fe7e6df2d8813e98 |
Change of Director's Interest Notice
|
2006-12-07 11:57:56 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca36a0785fa783be9ade55a3dd27dff2 |
Change of Director's Interest Notice
|
2006-12-08 10:40:38 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17a77ef6bbdd1459bca0c0849edf3e51 |
Change in substantial holding
|
2006-12-14 10:04:00 |
Investigates possible prevention of Type 1 diabetes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1dca2543f2d2a2b555b8479f63163751 |
|
2006-12-15 16:16:13 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21a9adf8ce1e0aac27e425aed04ff960 |
Change of Director's Interest Notice
|
2006-12-15 16:19:17 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17e1e450757468351869205a59205127 |
Change of Director's Interest Notice
|
2006-12-15 16:28:27 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99faf6ee2edf8f6b41b6f8ce528d6df0 |
Change of Director's Interest Notice
|
2006-12-19 09:52:46 |
Granted Approval to Manufacture Xeno Products for Human Use |
1 |
https://app.sharelinktechnologies.com/announcement/asx/720f7b1f3d3376018b8c0a51b40415c5 |
|
2006-12-27 17:39:33 |
Capital Raising Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89456da195c937b0e8345fbdaad89398 |
|
2006-12-29 15:31:28 |
Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d16326c8588c70fabe762177a7fda34 |
|
2007-01-17 11:47:44 |
Opens Share Purchase Plan Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2029308b28e851e4923374d666977173 |
|
2007-01-19 14:17:14 |
Appendix 3B and Relief Under Corps Act Section 708A(5)(e) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23fd79acec57395b134afe9b922e513c |
|
2007-01-24 14:21:18 |
Appoints CEO as Company Heads into New Phase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/058bb17dbf267e54e168e28d30d45b9f |
Director Appointment/Resignation
|
2007-01-30 08:36:34 |
To start clinical trial of Type 1 diabetes treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa10fe3c46090522c1a0617944a7ca43 |
|
2007-01-31 14:08:02 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eaa1eddd0647c157807c02271bdc1e5e |
Commitments Test Entity - Second Quarter Report
|
2007-02-02 13:43:39 |
Underwriting of Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc6772cf34c8aa9ac73fbb1fa4831f39 |
|
2007-02-05 09:42:40 |
February Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cd7f8958e5132a5b606dac69e86f7a9 |
|
2007-02-14 10:43:39 |
LCT Closes Successful Share Purchase Plan and Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d59fe91d749fc5e109e72d17fcaec7dc |
|
2007-02-22 14:38:36 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ca19bda7edae63312f7c8184b28c767 |
|
2007-02-23 16:08:07 |
Appointment of Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/534f734a430ad1d4617a51d377b51bb2 |
Director Appointment/Resignation
|
2007-02-26 16:18:14 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fc04932b9c0f418698321ad7c3dfaa2 |
Initial Director's Interest Notice
|
2007-02-26 16:23:19 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fff1f29f2e80792fc8b7fa6262bd54d3 |
Change of Director's Interest Notice
|
2007-02-26 16:23:21 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1233e60c62194ea4d1f5df3aeba74595 |
Change of Director's Interest Notice
|
2007-02-26 16:26:23 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a89677d876b3391735e7d9996a5227a |
Change of Director's Interest Notice
|
2007-02-27 10:26:58 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/375980648468d0a0a0b5236ff46f03fe |
Change of Director's Interest Notice
|
2007-02-28 15:32:19 |
Half Yearly Report & Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90c4f70f0b3f05bc96ea48340dad8f09 |
Half Year Directors' Statement
Half Year Directors' Report
|
2007-03-08 16:23:22 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9d31d248cc1189d50666ef185bea2a1 |
|
2007-03-22 11:18:15 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21b0528d40feda0c8f4cd457847e4738 |
Change of Director's Interest Notice
|
2007-03-30 09:27:24 |
Major Step Forward in Diabetes Patient |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c65e88a7f3529d402ca8cba8d675c90b |
|
2007-04-03 15:28:26 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3df969768b4fc524134eb204c2007945 |
Change of Director's Interest Notice
|
2007-04-12 08:42:41 |
To establish Level 1 ADR Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60357c8baf1517976ba17a77900963fe |
|
2007-04-17 08:48:46 |
MedSafe Allowance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b54b3843ed6db7ff3bd69e916562608 |
|
2007-04-30 15:32:28 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/926d424466963058a53128ae93d91f37 |
Commitments Test Entity - Third Quarter Report
|
2007-05-01 09:46:34 |
To Presentat at International LARTA Venture Forum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/954648c386f9b37f0a8d30982b2c6de3 |
|
2007-05-02 08:58:56 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f256aec534b25fd758999c71f3fd665 |
Notice of General Meeting
|
2007-05-16 10:51:49 |
May Newsletter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1179dbda95d7b616459d87651f7fa0f2 |
|
2007-05-22 09:28:26 |
IANZ Accreditation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0eb0e7d414600f371f2f624318ba7712 |
|
2007-06-01 15:29:27 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1891a767e1238ccc5bcd13acee96b938 |
|
2007-06-07 15:48:47 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfde1cec535e00a02502f9b28de330ed |
|
2007-06-07 15:56:55 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/375af4303f898ff22358db36520fbc0e |
Change of Director's Interest Notice
|
2007-06-07 15:58:57 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa6cfd6e9e5c7d2440fe30218eb9ea62 |
Change of Director's Interest Notice
|
2007-06-07 16:00:58 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e34b65894f6aef745ec27c673c27051 |
Change of Director's Interest Notice
|
2007-06-07 16:00:59 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8301b13672dcd67b0843622767a1f7f |
Change of Director's Interest Notice
|
2007-06-14 08:47:44 |
Russia 1st Transplant Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12e9b228d5ec0e7ccdf74a88eee631d3 |
|
2007-06-19 16:11:10 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6402ab6b0fbee4d9b5cd9d5cd9f0f22 |
Change of Director's Interest Notice
|
2007-06-25 11:16:14 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/342e4e8619a32395a32494acf1c8ce39 |
Change of Director's Interest Notice
|
2007-06-27 14:42:41 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b91eb6b21ae7d1e9cf3b1763ba4152f5 |
Change of Director's Interest Notice
|
2007-06-28 09:13:12 |
Director Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f10520bbb566cd891dd03d44459918d2 |
Director Appointment/Resignation
|
2007-06-28 09:56:54 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2baf54d509ed897b9327ae1f1d25ee01 |
Final Director's Interest Notice
|
2007-07-02 09:15:12 |
Channel Group |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cb76b606dc3dedd57593e8251d023c9 |
Company Administration - Other
|
2007-07-05 08:53:50 |
EDG Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00021fd8854ad05acceabd87118ab0e5 |
|
2007-07-18 08:54:51 |
LCT Increases US Investment Support through ADR Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/584e481b644a8e132b2bdcb24592f78a |
|
2007-07-31 09:40:37 |
Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83612e7d62dbea7d4d7c786083705d43 |
Commitments Test Entity - Fourth Quarter Report
|
2007-08-01 09:30:28 |
Journal Endorses Durability of LCT Biocapsule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/deaa5770d3dd6841ba4b7329683965b1 |
|
2007-08-03 09:14:13 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d4b18b7af3aa3e5fb1d6414fb0dfcb9 |
Change of Director's Interest Notice
|
2007-08-23 15:21:19 |
LCT Appoints David Brookes as Independent Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e326266b8769cd79923d0211640e0a2 |
Director Appointment/Resignation
|
2007-08-23 15:27:25 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8d4914a57017373896073419e58ecf0 |
Initial Director's Interest Notice
|
2007-08-24 14:41:40 |
Resignation of Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3ad591d03c8d64e5e97834a6f77dfa0 |
Director Appointment/Resignation
|
2007-08-24 14:46:45 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ceb7fcbcd9b27e093c28fc810b7538eb |
Final Director's Interest Notice
|
2007-08-29 10:11:09 |
LCT Featured on ABCTV Program, 7.30 Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2492687b01f28a1c31b24c1ab9858a83 |
Company Administration - Other
|
2007-08-31 15:38:34 |
Appendix 4E and Commentary |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6dd0482eb38eace0800e6f708132635d |
Full Year Directors' Statement
Full Year Directors' Report
|
2007-09-12 09:03:55 |
LCT Receives Approval for DiabeCell Clinical Trial in NZ |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1bd554afc0a86b7ed92c99431af0e8ab |
|
2007-09-28 15:05:55 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ec4032dd8eb20c17135237f7a10a398 |
Full Year Directors' Statement
Full Year Directors' Report
|
2007-10-03 11:09:58 |
LCT To Raise $2.4 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85fc2cff5aa3e51a080b024987e9f26b |
|
2007-10-09 08:45:43 |
Positive Preliminary Data on DiabeCell Phase I / IIa Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d70055ee49f336b05309b894ba8b77e0 |
|
2007-10-22 08:27:21 |
Further Positive Preliminary Data On DiabeCell Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f1efdbd3365cf37100f5f30ca6eec843 |
|
2007-10-23 08:45:38 |
LCT Presents at Rodman and Renshaw Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da781791014687629a05ba3db104412f |
|
2007-10-25 09:51:45 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7c6cbb1b2b4d6a4ab9d2e0b040358d9c |
|
2007-10-26 15:51:47 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76232875ac7d28f33c9fb0424b699112 |
Notice of Annual General Meeting
|
2007-10-26 16:32:29 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b4f728e12850a8b7094bb616c4bb38d |
Full Year Directors' Statement
Full Year Directors' Report
|
2007-10-26 16:37:35 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c33565a0a1f5a2bb2d38c4dac029fd55 |
Notice of General Meeting
|
2007-10-29 10:19:13 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f08ab188b848f16e5311290c606935db |
Suspension from Official Quotation
|
2007-10-30 09:30:40 |
LCT Announces $6.4m Capital Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8d0ace747dba41318366fbc54f6400f |
|
2007-10-30 09:31:27 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92f140831d96b2dab9e938f60fb0e29a |
Reinstatement to Official Quotation
|
2007-10-31 14:13:02 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4fa8b67c1d01891fe9662ac8ac351b06 |
Commitments Test Entity - First Quarter Report
|
2007-11-06 13:35:28 |
LCT Receives Initial NaviGroup Funding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/54e0cf00e8501d1621d5ce49c5a27e88 |
|
2007-11-08 15:03:01 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3db6ef0e55da924eb2e3979b4d953ab |
Becoming a substantial holder
|
2007-11-08 15:59:57 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40d22aa39d6078e31c752d128471b7f8 |
|
2007-11-21 10:35:32 |
Form 604 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93795642a7cf75abe439987a64ecc484 |
Change in substantial holding
|
2007-11-22 11:57:52 |
LCT To Cancel Rights At 20 Cents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fee7032e3f587f629dbff542d5d8598c |
|
2007-11-27 12:32:20 |
LCT Updates Shareholders on Clinical Trial Progress at AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b661e5fb2cca42a5db011d38baf8de5f |
Chairman's Address - Other
|
2007-11-27 12:34:18 |
Living Cell Technologies AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef690fe781531c00b33c6e6c628ebdf9 |
Chairman's Address to Shareholders
|
2007-11-27 14:56:38 |
Results of AGM Held on 27 November 2007 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42ee0da635f7c1e3dab4b1ba43da6f41 |
|
2007-11-27 15:07:01 |
Results of General Meeting Held on 27 November 2007 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49c6f56464d9a7f7f4f8e78fabb1943e |
|
2007-11-30 12:30:27 |
LCT Receives A$6.0 M In Capital Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f37c05f3ae4a08f9010ac0655e791d57 |
|
2007-11-30 16:24:21 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4465c695b741802fe1f5ce576fc098b |
Change of Director's Interest Notice
|
2007-12-05 16:00:59 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa5d57d2e5587f7dc74b9da91a2a730f |
|
2007-12-13 17:39:34 |
Becoming a substantial holder from AXA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8be55395b0ec35c41a684abc1ce9dee3 |
Becoming a substantial holder
|
2008-01-08 09:52:49 |
Living Cell Technologies Appoints New US Based Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90fa489340a4043e95cd71b7b8810c48 |
Director Appointment/Resignation
|
2008-01-08 09:57:56 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/598524833d73c4ea44fa8cfc15f0042b |
Initial Director's Interest Notice
|
2008-01-09 11:29:15 |
LCT to Receive US$6.0M through Exercise of Option |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82eb33e3e360e34f6e62cf62258e1403 |
|
2008-01-25 13:37:35 |
Conversion by Noteholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36ffaf4cc58fdbe31d4e917e0ef5f78e |
|
2008-01-31 10:53:44 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5af88b70bc716910b21132a9b54e2bf |
Commitments Test Entity - Second Quarter Report
|
2008-02-01 11:57:56 |
Appendix 3B and Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39a60ae84777819262ebed8de5d84790 |
|
2008-02-04 17:10:05 |
LCT NOTICE OF GENERAL MEETING |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9c87f753a78ae7b93894630a95692f7 |
Notice of General Meeting
|
2008-02-12 09:57:55 |
Diabetes Trial Supported By US-Based Diabetes Foundation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0045b5c6e606253eb72eed88bf1529ad |
|
2008-02-13 11:10:08 |
LCT to Present Positive Preliminary Clinical Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84cb7e89590b134b9bd3c1b98ab0c6f6 |
|
2008-02-13 12:30:29 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7f2d7c16e71707b28f9b01a03c1c58b |
Change of Director's Interest Notice
|
2008-02-13 12:36:35 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d314388583bcf38341af78b678dfe678 |
Change of Director's Interest Notice
|
2008-02-27 12:31:24 |
LCT and US based Barbara Davis Center collaborate on trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9100e5854f9684605f5c2cfc1900b809 |
|
2008-02-29 12:28:20 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bbf46b942269c90c951eb7ce5a89dfe1 |
Half Year Directors' Statement
Half Year Directors' Report
|
2008-03-07 12:30:29 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25f4c3ac38c798e6a271bd58e1429586 |
|
2008-03-14 14:15:14 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9422867f62a2e58b1bccc3a4f47622ce |
Change of Director's Interest Notice
|
2008-03-17 13:04:58 |
LCT ISSUED FOURTH US PATENT FOR DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e437a53092d89f58594984749d325c7 |
|
2008-03-19 09:07:05 |
LCT receives US $6million in Share Capital |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34d5762e3fb554aa2b35bf1be725009a |
|
2008-03-19 13:52:51 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2166b61dea070ee85e0f814ccc898881 |
|
2008-03-19 15:14:11 |
LCT Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e90338d7979237c9f52b926e08e56726 |
|
2008-03-20 10:45:41 |
Form 603/Form 605 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/775835979a9168432662c896d1283a9a |
Becoming a substantial holder
Ceasing to be a substantial holder
|
2008-03-20 13:28:27 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbdd67a0ed19de4a6b5829cc450c230c |
Change of Director's Interest Notice
|
2008-03-28 08:29:43 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/994a19bcb965397f063e50024c255cc2 |
Change in substantial holding
|
2008-03-31 09:24:21 |
LCT Announces Compelling Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/daf4008393405f7ae918d27bbb6259f5 |
|
2008-04-02 08:57:55 |
LCT Showcases Proprietary Nanobiocapsules at NZBio 2008 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1922bec84096cb6122130c2ae9aa3c70 |
|
2008-04-30 10:56:51 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8bfc87b5f66b70e4e87f665f726e76d5 |
Commitments Test Entity - Third Quarter Report
|
2008-05-08 10:31:29 |
LCT Prepares to List on the International OTCQX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/671544b019dba5761f1a28868fbeac25 |
|
2008-05-08 11:27:18 |
LCT Diabetes Treatment to feature on Channel Ten News |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d4050ea4bafe0e25512d61844c69abb |
|
2008-05-12 14:24:22 |
LCT Presents Encapsulation Technology at Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1086b95c7e3905c663e3358913f779d8 |
|
2008-06-03 09:26:20 |
LCT lists on International OTCQX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/632cda0cad3db225c9a711c4c9723c76 |
|
2008-06-04 12:01:00 |
Appendix 3Y Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9869142b221f20e9f2a5cbd105377a0 |
Change of Director's Interest Notice
|
2008-06-05 10:09:01 |
LCT Expands Diabetes Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9008603a4299f3567306a48cc2b68a4b |
|
2008-06-20 10:01:55 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71cbcf78c12d589c7c173d077af416d2 |
|
2008-06-25 12:05:56 |
LCT Confirms Insulin Delivery from Implants |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b736c0f14a2a44a11b7bfb21b50954d |
|
2008-06-26 10:55:53 |
LCT Informed of Progress for Diabetes Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d929106794a39e918d277884463b4225 |
|
2008-07-14 11:24:23 |
Quarterly Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bf2867b8f7d306ef596a492cf9deb60 |
|
2008-07-17 10:25:23 |
LCT Hosts Diabetes Seminar of World Leaders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82fce671560d3d264ebf1512a672369d |
|
2008-07-22 10:26:21 |
LCT Reports Clinical Benefits |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbe6091629749865e1f24e6c2ee04d1a |
|
2008-07-23 09:21:19 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8e3b461ac966efb76b645b89dc2601d |
Change of Director's Interest Notice
|
2008-07-29 10:55:53 |
LCT Expands Management Team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06e54c1bd6793b15e712f93eeff95ebf |
Director Appointment/Resignation
|
2008-07-31 10:38:14 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5d140ae7982054989b6e4fa375bf8b32 |
Commitments Test Entity - Fourth Quarter Report
|
2008-08-29 17:17:04 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8533e40071335b07088002ce4367e340 |
|
2008-09-23 16:19:16 |
Audited Financial Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ae7dc8d94bee3b4501a7a6763bba63c |
Full Year Directors' Statement
Full Year Directors' Report
|
2008-10-07 09:19:17 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67edf8178adc31df91cee5d40e602dea |
Notice of Annual General Meeting
|
2008-10-07 09:37:33 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/676858f27ae8af0bbb59f261dc4453e3 |
Full Year Directors' Statement
Full Year Directors' Report
|
2008-10-21 10:03:54 |
LCT Receives Ministers Approval for NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b37b4d282676ee8aad0c4e8c5b1791c0 |
|
2008-10-22 14:39:38 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32f39223f528b1371a618e75a9069e31 |
|
2008-10-23 10:51:45 |
LCT Expands Production Facility |
1 |
https://app.sharelinktechnologies.com/announcement/asx/494b88f47fd6ec4dc3c373d12d4cbbf9 |
|
2008-10-31 14:46:32 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d4e4ecdffbb563975f1ba09b3c69fb2 |
Commitments Test Entity - First Quarter Report
|
2008-11-06 13:33:30 |
Annual General Meeting Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef27e2cfc9e5ebea7ca30b576afd0016 |
Chairman's Address to Shareholders
|
2008-11-06 16:47:45 |
Annual General Meeting Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf93e8c2b5852784321adc9ff8357943 |
|
2008-12-05 14:05:02 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/194882baeeff75e681bd7e3cd17221b5 |
Change of Director's Interest Notice
|
2008-12-11 10:24:18 |
LCT`s NeurotrophinCell effective in Parkinson`s disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8101b7f8cc1f7e0e8643a81653b214e |
|
2008-12-18 08:42:41 |
Collaboration with Centocor Research and Development Inc |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a475c8ab29f664fe2771345a3759932 |
|
2008-12-23 10:42:37 |
Cash conservation and change of CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e6c834b3d249477ee83c5eae1ac2683f |
Company Administration - Other
|
2009-01-16 12:05:04 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/41deb5115469b0f79fa749108822ff36 |
Change in substantial holding
|
2009-01-21 12:08:07 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bda9061cfb8689d535f2fa606ada3df |
Change of Director's Interest Notice
|
2009-01-30 16:29:21 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/944c7c7d4956b062a6da2d4aea8a1426 |
Commitments Test Entity - Second Quarter Report
|
2009-02-11 09:39:35 |
LCT reports substained benefit with DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2af6db33f42e1f500c7cc98ef56b65a |
|
2009-02-27 17:10:52 |
Appendix 4D - Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2d87530caec03ce178a6f446cc5a75b |
Half Year Directors' Statement
Half Year Directors' Report
|
2009-03-12 10:06:05 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/776027aae0824d6ad3ec03d521f427c8 |
Change of Director's Interest Notice
|
2009-04-06 11:40:36 |
Clinical Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9274686dd04b44808f7719ed22b8ec6a |
|
2009-04-06 17:21:16 |
Change of Registered Office Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/735c7ba786fd5b2be7a6f5a2fe7ef30d |
Details of Registered office address
|
2009-04-08 08:27:51 |
LCT comments on Report on Safety of Pig Cell Transplants |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d15d0ded0f4cb7a687c0c55931858e0 |
|
2009-04-17 15:40:35 |
New Zealand Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8de15272a2f6b32d4cbb3715075ded2d |
|
2009-04-27 08:46:33 |
LCT`s New Zealand Pigs Free of Viruses |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3cbabf3f432c5c7d01e5892ec7301804 |
|
2009-04-30 11:56:51 |
Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97226179b6349d7e17b4f038891f92b1 |
Commitments Test Entity - Third Quarter Report
|
2009-05-01 16:15:13 |
LCT Director Steps Down |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c852968d29d16bb3f9053ed730d7db3 |
Director Appointment/Resignation
|
2009-05-01 16:54:54 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55681aa4c6490245d0ce87ce7dfcf4da |
Final Director's Interest Notice
|
2009-05-05 12:05:00 |
LCT Clinical Trial 2 Patients achieve insulin independence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/730d01ebde5b5b6d65a0130ba9099ab5 |
|
2009-05-22 12:09:07 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a03f7712a3ff0613925afa2ae4ea145 |
|
2009-05-22 16:26:18 |
Living Cell Technologies - Capital Raising Cancelled |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04deca29273b4eefbff89f07f6352134 |
|
2009-06-10 17:00:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f78e4807c2a6a2e602588eadb5140683 |
Change of Director's Interest Notice
|
2009-06-10 17:01:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7abf1f9a758c468654934ef28d44054d |
Change of Director's Interest Notice
|
2009-06-15 09:51:49 |
Response to ASX Query re Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1437faf25fac2c23a536ec6728d68d1 |
|
2009-06-19 10:19:14 |
Revised Conditions for LCT NZ Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5edf74da2e7dd6c98df7a0c4af3514ce |
|
2009-06-24 10:14:10 |
LCT Diabetes Clinical Trial authorized by NZ Government |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec9afcd09ea9bb1fdecbe0326a813eac |
|
2009-06-29 13:56:54 |
Investor Briefing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca2e449b75d5362007c2d97900516bbc |
|
2009-07-02 09:38:35 |
New Pig Breeding Facility Opens - NZ Diabetes Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f6a5f92c639e595bd7406d5088ce654 |
|
2009-07-06 09:03:59 |
Commercialisation in Russia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02597f9464e6a58791dcf682910627da |
Company Administration - Other
|
2009-07-08 08:40:38 |
LCT Cells may treat hearing loss |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb4eda873ba3fae0b7da547a16d08c58 |
|
2009-07-22 08:45:43 |
LCT NZ Clinical Trials commence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/504de20f952e1a9a1fadf71d2bc7ed1c |
|
2009-07-27 17:02:59 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/128f603e2e788424ead3f97d2d56b92f |
|
2009-07-29 16:53:50 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/130258a49dfe5bc1ba04975bf5e24d5e |
Suspension from Official Quotation
|
2009-07-30 09:58:41 |
Share Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/697741e80d8eac304020968137903d6b |
|
2009-07-30 09:58:55 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ded0cf27570d642a603d751a41d28333 |
Reinstatement to Official Quotation
|
2009-07-30 14:23:18 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0943573dd9da96cc9ed529236b761aeb |
Commitments Test Entity - Fourth Quarter Report
|
2009-08-05 14:15:14 |
Appendix 3B and Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b02b6f26343df2a1f2753ff03afc740 |
|
2009-08-06 12:47:45 |
Appendix 3B (Amended) and Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24ab72318749a07b2298a35060e38d62 |
|
2009-08-07 17:29:28 |
The Death of David Collinson |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0856c4c7043a1458265bf11bf1bc149 |
Company Administration - Other
|
2009-08-10 10:06:53 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/698311c9f2e48c78212d6c45612f11f8 |
Final Director's Interest Notice
|
2009-08-11 16:52:51 |
Ceasing to be a substantial holder from AXA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47dec5d363d1986e9892b393aaeb9e93 |
Ceasing to be a substantial holder
|
2009-08-13 17:54:49 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/033777ee8fd74bc2e3b1d1802d38782e |
Details of Registered office address
|
2009-08-17 16:40:38 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39841216866318ebe6daf72b2471b984 |
Notice of General Meeting
|
2009-08-31 13:09:02 |
Appendix 4E - Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b67b95d17a5e1420cec4a4343c82db0 |
|
2009-08-31 13:18:17 |
Financial Report for the year ended 30 June 2009 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97dff949b9c74b2f7709f3047f5d97c7 |
Full Year Directors' Statement
Full Year Directors' Report
|
2009-09-17 12:45:45 |
Results of 2009 General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66d299483d64b7d9157d9634e9542ab3 |
|
2009-09-23 08:45:41 |
Appointment of directors and chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c2e5a796f99d23e7ef08996bac5e9a5 |
Director Appointment/Resignation
|
2009-09-29 11:00:58 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51896abbd08367f9301aa77ed6d5c32e |
Initial Director's Interest Notice
|
2009-09-29 11:01:59 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/743e5a9c67021099878c5c0954629634 |
Initial Director's Interest Notice
|
2009-09-29 11:04:03 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff7b8f7c11e65d8bfbf376def815dde7 |
Change of Director's Interest Notice
|
2009-10-07 08:24:51 |
LCT Reports Successful First Implant Of DIABECELL in NZ |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c5d7605c1e4e2baee824c869493c7bed |
|
2009-10-19 16:23:20 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/119ad4445d96d7325bdaa158903de897 |
Notice of Annual General Meeting
|
2009-10-19 16:41:38 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9978364ad58d3b8c3584e6b3190ed75b |
Full Year Directors' Statement
Full Year Directors' Report
|
2009-10-19 17:01:48 |
Additional Information to the Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f42fba326b9ded91ee06c4cfd17f1d74 |
|
2009-10-27 11:20:14 |
LCT Updates Progress with Diabetes Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38f61fffe7d1fa029ff262aa1ac9dcb7 |
|
2009-10-27 12:05:01 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc2b83d563eff84d87cdd41e865b0dfd |
|
2009-10-30 13:19:52 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/637129246e8da8783b28eb10dc0c8d35 |
Commitments Test Entity - First Quarter Report
|
2009-11-16 10:26:20 |
LCT Announces Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75be4c7e458e92e6dacd5a8a44b06346 |
|
2009-11-19 12:03:00 |
Chairman`s (Dr David Brookes) Address to the 2009 LCT AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3834eadc4e60c58b9655c2af35d6e498 |
Chairman's Address to Shareholders
|
2009-11-19 15:30:27 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f737b8b380dbb319ee1a6f434b779d4 |
|
2009-11-25 16:37:35 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45510b7d245fd4580ddd00c8e3f6d4f9 |
Change of Director's Interest Notice
|
2009-11-25 16:38:36 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c33e9bdf69cde81d97b041d0555f50e |
Change of Director's Interest Notice
|
2009-11-25 16:39:36 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50ea12f51ed64790dbbacf7dc26024b2 |
Change of Director's Interest Notice
|
2009-12-03 10:58:57 |
Director`s Participation in the SPP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20adea21bc887166896ba537af1b34f3 |
|
2009-12-04 08:45:42 |
LCT Clinical Trial Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10db73d6f24691835fc145a2f3e0fca6 |
|
2009-12-10 13:51:44 |
LCT considers Australian trials following lifting of ban |
1 |
https://app.sharelinktechnologies.com/announcement/asx/054476a759de56465e05bc55c56c8349 |
|
2009-12-11 12:10:09 |
LCT extends SPP closing date until 17 December 2009 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d94ae099a1848f527ca3a2a9dbf56960 |
|
2009-12-21 09:19:15 |
LCT signs new research collaboration and option agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ee56ba822c3a1aaf78c31c0cbdeb962 |
|
2009-12-29 08:44:47 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/510c929fbfaf964d930f3e9c8d380a70 |
|
2010-01-04 09:47:46 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bacf7a5edf263b264b6b193d6c3bef70 |
Change of Director's Interest Notice
|
2010-01-04 09:50:48 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5619c9114d91032309ecfb63a4e3fd3b |
Change of Director's Interest Notice
|
2010-01-04 09:52:51 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c5f999ce154bd0d6a0d9239be792793 |
Change of Director's Interest Notice
|
2010-01-04 09:55:53 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2281f94db46a18c2935237523a42a3e |
Change of Director's Interest Notice
|
2010-01-20 09:52:48 |
LCT Granted European Patent for NTCELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ff9e4ad0f524a5bb2d7e70cbbf39119d |
|
2010-01-27 09:59:51 |
LCT alerted to issue of fake share certificates |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f4e5b9f75c1ed2f965799c00b8f0cde |
Company Administration - Other
|
2010-01-29 15:11:06 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec8e100d57e63606b6cfa3066cf79717 |
Commitments Test Entity - Second Quarter Report
|
2010-02-09 10:15:09 |
LCT Receives 10% of US Based Wound Healing Company |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bfebe4032cbac57834b14c0e2dde8466 |
Asset Acquisition & Disposal - Other
|
2010-02-12 09:26:23 |
LCT Awarded NZ$4.04 Million New Zealand Government Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ff28bcc48be2cb333e14fdad73aa97e |
|
2010-02-25 16:19:16 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad8b10c698c1b6b4c7276539d2a0b56d |
Half Year Directors' Statement
Half Year Directors' Report
|
2010-03-10 08:56:54 |
Russia registers LCT encapsulation delivery device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/605c386bddf3b3e19d1ac0f71675876b |
|
2010-03-17 16:50:48 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad5362863bce3318d5cd94ca443558a3 |
|
2010-03-30 09:47:45 |
LCT Phase II Diabetes Trial Success - Approval to Progress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e428b768b06a8c8b6a3ae21a279b801 |
|
2010-04-07 10:27:19 |
Report from LCTs Russian Phase I / IIa Diabetes Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/36aaa3b818c2b4363997fdb34cc675b5 |
|
2010-04-08 15:04:58 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8df3f4668e7f970b839ca8209ba2d9da |
|
2010-04-27 08:36:26 |
LCT receives grant from Juvenile Diabetes Research Foundn |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eceaa52d2156b988224319ab4b567207 |
|
2010-04-29 09:34:28 |
Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/523759f6efacfa82bf188869cfa4f35e |
Commitments Test Entity - Third Quarter Report
|
2010-05-20 09:08:02 |
Living Cell Technologies - Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eda24cdfd1590a5c3cf8cf9100066d1e |
|
2010-05-28 16:58:57 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81720a1b1a419023cc387de9cf106f6e |
|
2010-06-11 15:50:49 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f6bc77db41ae7e9e1873a2a4b3b4a31 |
|
2010-06-22 09:08:04 |
LCT Options underwritten |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f945129cff28daf86b6fb8a5aa70aa94 |
|
2010-06-28 08:30:47 |
Presentation to American Diabetes Association |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f69edcf1a78b247b1abc9a371f494eec |
|
2010-06-28 09:09:04 |
LCT Presentation at American Diabetes Association |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79b5318e09ddb5b48103c4e07d1d03f4 |
|
2010-07-02 16:33:32 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50fa4acf6307fc01dd44f08f25c3cc49 |
|
2010-07-07 17:07:06 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2792c79532a730661908b56b6378eca |
Change of Director's Interest Notice
|
2010-07-13 09:04:01 |
LCT reports consistent benefit in DIABECELL NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b9016021980dfdaa66c5559dc4d484d |
|
2010-07-13 12:46:44 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4375d49e109a44106570eef371488481 |
|
2010-07-15 10:59:59 |
Section 708A (5) (e) Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/987a6f7dfc02105304aa763097ce5df8 |
|
2010-07-20 10:55:52 |
LCT Presentation to Australian Investors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4f18d62ea41b54144e01dc010e928ef |
|
2010-07-30 09:13:09 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef32224753e3f5a2ea612fc432958155 |
Commitments Test Entity - Fourth Quarter Report
|
2010-08-02 12:54:52 |
Appointment of Managing Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca76d89df0ad8fce399c8f3763b0d919 |
Director Appointment/Resignation
|
2010-08-04 08:46:43 |
LCT receives approval to expand DIABECELL NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2dfd9ce6d07da89615c0a4c7f5da699d |
|
2010-08-06 10:36:34 |
Remuneration of Managing Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a550b53a7160d2941b623acb9e845abd |
Company Administration - Other
|
2010-08-09 12:40:40 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97d49a6d81e76180dc81da16c6e04856 |
Initial Director's Interest Notice
|
2010-08-26 12:32:30 |
LCT Presentation to Australian Investors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6611d64cba5642670f7702e8be142b7 |
|
2010-08-27 14:06:58 |
Appendix 4E - Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8bf93e8253b8f7f9bfc49aaab750e147 |
|
2010-08-27 14:11:09 |
Financial Report for the year ended 30 June 2010 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ec1e9e15e589c4b4b7d4042468bd25b |
Full Year Directors' Statement
Full Year Directors' Report
|
2010-09-23 09:05:00 |
LCT Restructures Executive Team for Commercial Focus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5cc76665185a8903774bfb214ed6788 |
Director Appointment/Resignation
Company Administration - Other
|
2010-09-24 08:38:37 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48543d625758087c46f9baf2a7a32ceb |
Final Director's Interest Notice
|
2010-10-05 11:34:32 |
LCT Managing Director to speak at American Investor Forum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e34720799d7793f6f9ba72aeedb7b8a |
|
2010-10-07 08:50:48 |
LCT BIO Investor Forum Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ddea52a1130483a9193967b5c7fa923 |
Chairman's Address - Other
|
2010-10-18 17:05:02 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d16041130ac1d62f593cdbf18f8ef46 |
Full Year Directors' Statement
Full Year Directors' Report
|
2010-10-18 17:13:10 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb0bed9eabab110f31f6680dcd8fd5f3 |
Notice of Annual General Meeting
|
2010-10-27 11:09:05 |
LCT reports sustained improvement from DIABECELL NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50648bd073586b2604ac3f4ac7be6197 |
|
2010-10-29 13:47:35 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b92d4dbe4abc8fefde9cc850dd981129 |
Commitments Test Entity - First Quarter Report
|
2010-11-02 09:49:48 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73df199fa7fa59e995a96b962e2be17c |
Change of Director's Interest Notice
|
2010-11-10 10:27:18 |
Promising Preclinical Results with NTCELL in Parkinsons |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dedbfd9b520be5646e6da707338fe0ad |
|
2010-11-15 12:38:36 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/901ead2d89c553fd800c7c77068ceb55 |
Change of Director's Interest Notice
|
2010-11-18 09:51:45 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc2b86a05a99a55b14cbf22522d2c951 |
|
2010-11-18 13:38:30 |
CEO`S Presentation to the 2010 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a370a7674b1bda789b1abd535d57483b |
Chairman's Address to Shareholders
|
2010-11-18 15:13:04 |
Results of the 2010 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a83d2bc2d6383ab4ce1acfafc40e414 |
|
2010-11-18 15:20:15 |
LCT Appoints New Chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b6c0da9ba02df87dc62c6b15c81e9a1 |
Director Appointment/Resignation
|
2010-11-18 16:36:24 |
Lifting of Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90b5a38eff893db4b3255cfea0cecdd0 |
Company Administration - Other
|
2010-11-23 14:13:12 |
Final Director`s Interest Notice - Simon O`Loughlin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ca03882e2b6cefe6f76ab8158aa6849 |
Change of Director's Interest Notice
|
2010-11-23 14:18:17 |
Final Director`s Interest Notice - David McAuliffe |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24877988cb669a84f5161af58111db4e |
Final Director's Interest Notice
|
2010-11-23 14:22:18 |
Final Director`s Interest Notice - David Brookes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6641ba48c162e85723e2d01fd064cc62 |
Final Director's Interest Notice
|
2010-12-10 09:01:57 |
LCT`s DiabeCell Registered for Sale and Use in Russia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f23df851b305f8e4471704db971cf7ec |
|
2010-12-20 12:07:00 |
LCT Approved to Further Expand DIABECELL NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bca976c41c64e6271e429725208b5eb0 |
|
2010-12-21 12:14:10 |
Appointment of Alternate Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6577bf86d7473511bc403727196061f7 |
Director Appointment/Resignation
|
2010-12-22 09:43:42 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f773588a8faeb5fa63100dc7e8d3ba2 |
Initial Director's Interest Notice
|
2010-12-23 13:03:58 |
LCT Negotiating Funding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/21e577fc4f976becfc3e85dd19dd7e1a |
Company Administration - Other
|
2010-12-23 15:37:32 |
Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94bd6929b1b0e73078a0b33664eb79cb |
|
2010-12-31 09:46:43 |
LCT executes $5.75m funding agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e84d852eac76f715db0495db621f278 |
|
2011-01-04 12:00:53 |
LCT Completes First Closing on Funding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4779d4b858eb96a0075b28eba2a3e299 |
|
2011-01-04 12:04:02 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b43fdab85f4bb10f8ab2f53c8a4d17b8 |
|
2011-01-04 12:07:05 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2416172a2a76c513ad372850f16ac63a |
|
2011-01-25 13:10:10 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c7a2cb3fcaad51ac31c587d8bd2305a |
|
2011-01-25 13:14:12 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e93f5ba1b142c62ad80f426d69a672e6 |
|
2011-01-28 10:22:13 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/086a62d9dfb9d2cb2893698a8c54286c |
Commitments Test Entity - Second Quarter Report
|
2011-01-31 08:40:35 |
Share Placement with ASK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8901d5977f150d4c1cb0dec52422a9e6 |
|
2011-02-02 09:13:11 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44f026ffaf83160cbe92b5de70dbb871 |
|
2011-02-02 09:17:16 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4e74ff23f471217e67b203a55e3495a |
|
2011-02-16 09:14:10 |
International foundations team up to fund LCT NZ Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af3aab8d11636b190c09e8630e3896ce |
|
2011-02-24 10:26:16 |
LCTs encapsulating technology granted key Australian patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13a456ddf91da20a65a0859fd7e3feb5 |
|
2011-02-25 11:39:28 |
Appendix 4D and Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d8c90bd29a7858f9ed0b707b27ba1b3 |
Half Year Directors' Statement
Half Year Directors' Report
|
2011-02-25 12:07:04 |
LCT appoints investment banker to the Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad81072c946b25cfe46350e35a748221 |
Company Administration - Other
|
2011-03-01 10:11:06 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fc8177967e09690fee9cf426fc9409b |
Initial Director's Interest Notice
|
2011-03-03 10:11:09 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/973e154fb61fbed0d7f825b71d713955 |
Change of Director's Interest Notice
|
2011-03-07 10:38:34 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a4c8ad5aaf461a4e190a14e226cb800 |
|
2011-03-07 10:42:39 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99a2bfdb5d8e9eee64608b6ac988fe4d |
|
2011-03-08 14:56:55 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a55e564f42cde7b355710cceeb32e0d |
|
2011-03-08 14:59:58 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d906da5f540f7dcf8a5822fd412d4a35 |
|
2011-03-09 10:22:20 |
LCT receives funds from Pharmaceutical Investor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1be3cdbf558f03c223cd66610ab3c922 |
|
2011-03-14 18:37:28 |
Director resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbb69d896e3b88f671f257686810626a |
Director Appointment/Resignation
|
2011-03-15 12:36:34 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2410375e11885346ea434117ba37d0c7 |
Final Director's Interest Notice
|
2011-03-29 09:38:36 |
LCT Strengthens Board of Directors with New Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a39bfe54df0e3857d3f7beb43d34b9dd |
Director Appointment/Resignation
|
2011-04-04 14:35:34 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01649f2551e5007a0696fdcbcc5b4894 |
Initial Director's Interest Notice
|
2011-04-12 11:08:59 |
LCT and Otsuka of Japan Share Common DIABECELL Vision |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92d8791def6e90c8fdb55d1c3515405e |
|
2011-04-18 12:06:05 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8c3f513944f6d665995017be432b2f8 |
|
2011-04-18 12:14:13 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bbd76932a03bba3e09554875d3e63ef |
|
2011-04-20 09:24:21 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/df6058d7acf9c21205a78b099dc0444d |
Commitments Test Entity - Third Quarter Report
|
2011-05-03 14:26:19 |
LCT Approved for DIABECELL Clinical Trial in Argentina |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f145f036944f52cbad7099cb4364e7ed |
|
2011-05-04 09:48:46 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e3eeb9764237adcdcda328dd5803d69 |
Notice of General Meeting
|
2011-05-05 15:02:54 |
SpringTree tranches paused until July |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2220f09b9c1be9b08356d2f67ce09a0b |
|
2011-05-05 15:07:05 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee5c95d8c0ad30bc552be89846a8d583 |
|
2011-05-05 15:10:09 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cc743e4e6a2399351747cd065bbc6de |
|
2011-05-31 18:16:11 |
Change of Registered Office Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04565c6412f4e5411e4991280dc2032e |
Details of Registered office address
|
2011-06-06 08:27:51 |
LCT presents at World IPITA Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72e99c8d231a805a2d950099456020a3 |
|
2011-06-07 15:03:02 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbed3330394ebaedef217d5bdd5a4a14 |
|
2011-06-08 16:39:37 |
1st Presentation by Pr. R Elliott to IPITA World Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc94cc74cc249ece357624210006ad16 |
|
2011-06-08 16:46:44 |
2nd Presentation by Pr. R Elliott to IPITA World Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1db3acf23e15b553595f731852570f90 |
|
2011-06-08 17:05:03 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae6ccc722cc20d1afd3459d96d0a777b |
|
2011-06-08 17:05:03 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0cc7d22c18c53c70605c15938f3083b |
|
2011-06-10 12:25:23 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb4f77164b1a17dede4a863f4d8b9a28 |
|
2011-06-10 12:28:27 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e6fb71bd2f03994d443c090363dd022 |
|
2011-06-24 15:42:35 |
Resignation and Appointment of acting CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66311d6d0a5ec6874e8380687a1c5c5b |
Director Appointment/Resignation
|
2011-06-27 10:18:14 |
LCT Enrols First Patients in DIABECELL Argentina Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/254f8f5d481cc0f7a8082ad5436338fe |
|
2011-06-28 17:08:07 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/293ff44621c4c4e084ee223e66d0ce5d |
Final Director's Interest Notice
|
2011-07-12 10:08:07 |
Resignation of Alternate Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b96dad171cecc1bfeb562e011afa629 |
Director Appointment/Resignation
|
2011-07-12 10:11:10 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c9d3e48cccceba47be53c29b6eedbaa |
Final Director's Interest Notice
|
2011-07-20 12:14:11 |
Appointment of new Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0a7fbb78629e0416fb61c49968fa85d |
Director Appointment/Resignation
|
2011-07-20 14:06:04 |
Appointment of new Chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1829e9556a1c4397bec91a4b6a0e4743 |
Director Appointment/Resignation
|
2011-07-20 14:36:34 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ab1d2e87477e857d1bf0f952352dc53 |
Initial Director's Interest Notice
|
2011-07-26 09:02:58 |
SpringTree facility terminated by mutual consent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56dc3d292c46eed3f8e3a090d36e883e |
Company Administration - Other
|
2011-07-29 12:48:42 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1e7c02fb4456074c27ce8ef65afca118 |
Commitments Test Entity - Fourth Quarter Report
|
2011-08-02 14:30:30 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e807b3bfae4e49d248e5363c86a851e7 |
|
2011-08-02 14:32:31 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bf5f9515166f03f97b846e4117b7b8c |
|
2011-08-22 09:20:18 |
First Argentina Patients Implanted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55beecccc80e669d8c976699bc65460f |
|
2011-08-25 14:52:46 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/52ada5d9e0849c53ec37790bcf344f14 |
Full Year Directors' Statement
Full Year Directors' Report
|
2011-09-05 12:20:18 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c44234f77cf02bbd2adb600ee219f00e |
|
2011-09-05 12:23:21 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1feea810a87f5135f3389a9d78207fd4 |
|
2011-10-04 09:01:57 |
Research collaboration with Centocor terminated |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb0619dcb26841dc69ffa87b42a91cd7 |
|
2011-10-11 09:34:32 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/644bb3a9f5ea5a97247cdc900e379a2c |
|
2011-10-11 09:38:36 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2fed0a5d20cccc78ea8fa7000047ce2 |
|
2011-10-19 10:06:57 |
Otsuka commits $A25 million to JV with LCT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b676f6ba13901089a91cc32a9af8fc8 |
|
2011-10-28 14:19:07 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4ae641eae4c69aa2525646417c2d35cf |
Commitments Test Entity - First Quarter Report
|
2011-10-28 15:29:27 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99a6419ec33c8d70ab6196523f36ab47 |
Notice of Annual General Meeting
|
2011-10-28 15:36:33 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f8e4282221da8faf53acfc66e9ee369 |
Full Year Directors' Statement
Full Year Directors' Report
|
2011-11-02 08:47:45 |
Settlement of $A50 million JV to commercialise DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1796bac6c9317403f3a5b171c1b48fa |
Asset Acquisition & Disposal - Other
|
2011-11-04 12:30:27 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8163e269b8e4ed5c2f44d7210466a6dc |
Change of Director's Interest Notice
|
2011-11-18 16:02:01 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53b5d869e03cc609b8d9fd11891a00d1 |
Change of Director's Interest Notice
|
2011-11-24 09:36:32 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8fb589880a22fa318263439f8c5eb3e |
Change of Director's Interest Notice
|
2011-11-28 11:33:30 |
Chairmans Address to the 2011 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cdb56cb271964f28523653504c99a9f |
Chairman's Address to Shareholders
|
2011-11-28 11:40:36 |
CEO`s Presentation to the 2011 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a43f70f8b6d4dbb63a8599e5eccc17db |
Chairman's Address to Shareholders
|
2011-11-28 17:17:16 |
Results of the 2011 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5ff756619639d4d44eee41f4831996d |
|
2011-11-30 09:28:24 |
Amended AGM Poll Result |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7198de817fbcb63a9be4765641da34f6 |
|
2011-12-05 10:50:47 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19a262b1549bc02b169af605c69c8aac |
Change of Director's Interest Notice
|
2011-12-13 15:38:36 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8937977f21c231b44b904e4d039f5f43 |
Change of Director's Interest Notice
|
2011-12-13 15:46:45 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90ccd374c88e7cbb1246f9b89a15f588 |
Change of Director's Interest Notice
|
2011-12-13 15:54:53 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3791c328928b2e07d09c2346dff1e129 |
Change of Director's Interest Notice
|
2011-12-28 09:33:30 |
LCT appoints Chief Executive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/45d0ca7fd21d431c5847dee07fd0131a |
Director Appointment/Resignation
|
2012-01-27 12:35:30 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f81d7b53aba167c987f4da48ba09218 |
Commitments Test Entity - Second Quarter Report
|
2012-01-30 16:15:10 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38ec38c6132b95f01f204eced88eb95c |
Becoming a substantial holder
|
2012-01-30 16:20:18 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28992ebddfde8d706bb7cc4deeae90dd |
Change in substantial holding
|
2012-02-02 10:36:30 |
LCT granted USA Patent for Auckland Island Pigs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6d7a70545324889152cfae21f1dfb80 |
|
2012-02-16 16:56:55 |
Price query response |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57321d81ad463d5e551ecd3616567c75 |
|
2012-02-28 14:17:06 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be3bceb7c41770f06b0a53c3cfafaefb |
Half Year Directors' Statement
Half Year Directors' Report
|
2012-02-28 15:44:35 |
LCT completes pre-clinical studies of NTCELL in Parkinson`s |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7936fa274912cdf116bbbdd7fbb3c4fb |
|
2012-02-28 16:07:58 |
LCT granted E.U. Patent for tissue engineering |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e7dc76564a866d9f25f86f460494356 |
|
2012-03-20 09:11:08 |
LCT announces Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8beba8f06b3a19e83541fcccadd675b0 |
|
2012-03-21 09:09:07 |
LCT Presents Novel Parkinson`s Disease Treatment Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/95235e35201aba193d6c2c2c59a4938a |
|
2012-03-30 13:40:38 |
Share Purchase Plan documents mailed to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94844cc5ff18a46bdd14847910c609b3 |
New Issue Letter of Offer & Acc. Form
|
2012-04-17 09:09:07 |
Dr Barry Snow to lead Parkinson`s trial for LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bc2d938d7c7d4a43b9ae3e06a846c2c |
Company Administration - Other
|
2012-04-30 09:44:36 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/59cd5e7439a231489f8697d04c378908 |
Commitments Test Entity - Third Quarter Report
|
2012-05-01 12:26:24 |
LCT`s Share Purchase Plan successful |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b52c5ebadfdcc3a73c88ea506178caaa |
|
2012-05-03 12:11:09 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/058136959cef5d59f8042f3467ba3e4d |
|
2012-05-03 12:14:12 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d81a8afb6f85f7104247edcce9deb228 |
|
2012-05-04 12:05:05 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e7d9f8bf6b8ebbf151284ec10f805b0 |
Change of Director's Interest Notice
|
2012-05-17 15:08:59 |
LCT`s DIABECELL trial extension approved |
1 |
https://app.sharelinktechnologies.com/announcement/asx/802a62b7e2b991d7936a748ee8ea7934 |
|
2012-06-01 12:11:09 |
LCT restructures for next stage of growth |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d00010f9f5b66e9638bbd112cfa5b07 |
Company Administration - Other
|
2012-06-06 12:55:55 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ee7cd3acb1c04bac67cb7ff611f7a21 |
Daily Share Buy-Back Notice
|
2012-07-23 09:26:25 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38ba74e78a7061ccda9f9534c921f49b |
Commitments Test Entity - Fourth Quarter Report
|
2012-07-24 11:23:22 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a97fe52a6a10c52a9672c38a4a674c9a |
Change of Director's Interest Notice
|
2012-08-06 11:00:58 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f493177e7c501a324c7abbb5cb692757 |
Change of Director's Interest Notice
|
2012-08-17 10:38:36 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a60836db25af9ca8f11a87c59afd3c59 |
Change of Director's Interest Notice
|
2012-08-29 16:51:48 |
Preliminary Final Report for the year ended 30 June 2012 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96e0d84a902f3fa26f50c5520cdc1bef |
Full Year Directors' Statement
Full Year Directors' Report
|
2012-09-26 12:49:44 |
LCT announces positive DIABECELL Phase I/IIa trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f07895434434aa74b60dbcd8165ca39f |
|
2012-09-28 10:47:44 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fe90d819ec8234fe6950e561a4c2cfa |
Change of Director's Interest Notice
|
2012-10-03 15:01:56 |
Form 492 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f014a6ec4a1dd970a45925113ce26cd |
Security holder details - Other
|
2012-10-04 08:45:43 |
Authorisation of Ph1 trial of NTCell in Parkinsons Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ed7bb1ca91da2ed191672fdd12fabca |
|
2012-10-15 12:05:02 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f42f7949bb03c06ccef15e66bcc29b7 |
Notice of Annual General Meeting
|
2012-10-15 12:12:10 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04bbfafc91bf6f96ce04934d38d75bf2 |
Full Year Directors' Statement
Full Year Directors' Report
|
2012-10-30 08:45:43 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb610dcb3180784f7ddf8585fa09e5cf |
Commitments Test Entity - First Quarter Report
|
2012-11-02 10:50:42 |
Six reasons to invest in LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5aaddaa235278f7fbfdfd8490f284ce |
|
2012-11-05 09:33:28 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d783c34c288ab65b70803764d1a743d4 |
Change of Director's Interest Notice
|
2012-11-16 09:32:31 |
Ethical approval for LCT's NTCELL Phase I trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0bdf32b687718c3f2c043ebc6f5f081 |
|
2012-11-16 09:47:42 |
LCT CEO Dr Andrea Grant appointed Managing Director |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bce1e134ded01faaec4ccd740795c167 |
Company Administration - Other
|
2012-11-16 14:31:30 |
Chairman's Address to the 2012 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44d2bc3e4f05d2d4b67a131f08f5e0cb |
Chairman's Address to Shareholders
|
2012-11-16 14:35:33 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e5f22227906eda4040cf63e32faa92c |
Chairman's Address to Shareholders
|
2012-11-16 15:46:45 |
Results of 2012 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e044d2a17a2f563f593aa906bd2e976 |
|
2012-11-19 15:58:57 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20ddbcbbb3d6a876279cb0d005d548ba |
Initial Director's Interest Notice
|
2012-11-20 15:41:40 |
Alteration to issued capital |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4faa794ca106029743bd02f33eefa32d |
Alteration to issued capital
|
2012-11-22 10:35:31 |
Strong interim results in Argentinian DIABECELL trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5c09fb0660377a7fde3bed3fa36bb54 |
|
2012-11-22 10:48:40 |
LCT starts DIABECELL Phase IIb trial in Argentina |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a93746486d734090af63456c7973334 |
|
2012-12-10 09:04:03 |
LCT appoints Chief Science and Medical Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa81a3843632890834b4d23aba116edf |
Company Administration - Other
|
2012-12-17 12:36:29 |
LCT & Otsuka to co-develop NTCELL for Parkinson's Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c7620e688b8e79cb156fb55c7e7309e |
|
2012-12-17 12:42:40 |
Open Briefing interview with MD and CEO Andrea Grant |
0 |
https://app.sharelinktechnologies.com/announcement/asx/957f941c4b5e4af13633dae7736a0f43 |
|
2013-01-24 14:57:56 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e70aeedfcea575930579c3a1aeaab1a1 |
Change of Director's Interest Notice
|
2013-01-30 09:17:16 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/61bea0ef7ba1950737ccf6cd77c28ff9 |
Commitments Test Entity - Second Quarter Report
|
2013-02-12 12:25:16 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59d7c560c911766c9e4ab0aa2ead64a3 |
Change of Director's Interest Notice
|
2013-02-27 12:29:19 |
Appendix 4D and Half-Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d74443ddcde766e5a6d44372be7615d1 |
Half Year Directors' Statement
Half Year Directors' Report
|
2013-02-27 12:30:12 |
Announcement on Half-Year Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5bf47c7b1ca84fa233f461e1c8b1e3e5 |
|
2013-03-20 08:28:41 |
Living Cell Technologies Awarded NZBIO Company of the Year |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e82a93aeeccc8978b2f5e87848c52ec1 |
Company Administration - Other
|
2013-03-21 08:54:50 |
Open Briefing - CEO on Strategy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28f09a96633160e3a7903b537741c39f |
|
2013-03-21 08:59:58 |
CEO on Strategy - Audio Interview |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbacd9a95dd97a02064ab193aee5d70d |
|
2013-04-29 09:37:35 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5c2abd1c7d50beb9cf9fe1d4acca7d5 |
Commitments Test Entity - Third Quarter Report
|
2013-05-09 14:31:28 |
Open Briefing LCT Clinical Trials Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e069e7b32aeb2c4711a21f6226b297f |
|
2013-05-29 11:07:05 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3618a67d393cd9c4c27533157c88f157 |
Change of Director's Interest Notice
|
2013-07-08 12:02:00 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd1144bec4727151f771e1e6be4224ce |
Details of Share Registry address
|
2013-07-31 08:52:50 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb88c1d4681028be31c7d5b673f32fd9 |
Commitments Test Entity - Fourth Quarter Report
|
2013-08-01 09:42:40 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa6c35e5d29491b0a71982fbfdf2a2a9 |
Change of Director's Interest Notice
|
2013-08-27 09:56:50 |
Preliminary Internal Review of Dia12 Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e639fe7fda7f1dcbbba7ab0c6a8d141 |
|
2013-08-29 13:46:44 |
LCT Announces Change in Regulatory Strategy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c7e14278bbe3b98fce4681046b4e6ab |
|
2013-08-30 12:02:56 |
Appendix 4E and Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85ccfa0f16bc6b200c17454809fd32e8 |
Full Year Directors' Statement
Full Year Directors' Report
|
2013-09-16 13:32:28 |
Publication of pre-clinical trial of NTCELL in Parkinson's |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad01728572d22c2b539b72748a658896 |
|
2013-09-20 10:30:23 |
First patient successfully implanted with NTCELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c14b39bbf78f9fdeebc9c9d52cfb6863 |
|
2013-10-15 14:31:29 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa8a616bfe0fe06ae063ec0beb3833d0 |
Notice of Annual General Meeting
|
2013-10-15 14:34:31 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3108d4fe9b0c8a2f1c97d2c40441f69d |
Full Year Directors' Statement
Full Year Directors' Report
|
2013-10-28 15:23:21 |
Australia Biotech Invest 2013 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce37660c783cad7f677b90eaa4851e3c |
|
2013-10-30 08:30:51 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4948c0b391a82dd372d99ca962c975cf |
Commitments Test Entity - First Quarter Report
|
2013-11-01 09:32:29 |
Saftey and efficacy findings of DIA 09 study of DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fee6ccf62fb00aa9d1845bfe9aa71cc2 |
|
2013-11-19 12:01:00 |
Chairman's Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/019b88e3c2c5f3076e18d0e27e7e6b2d |
Chairman's Address to Shareholders
|
2013-11-19 12:06:03 |
Managing Director's Presentation to AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8406ed4264f2a6e36905de8bdd7fc41c |
Chairman's Address - Other
|
2013-11-19 12:55:54 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/363bfeb696aa2fb29b964324474a6874 |
|
2013-11-25 09:54:49 |
NTCELL clinical trial - Further patients approved |
1 |
https://app.sharelinktechnologies.com/announcement/asx/828191c7325d553cc2bc53473a2f36e9 |
|
2013-12-04 14:02:58 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6452b0cba7cd0c062ab4b0f3abb7863d |
|
2013-12-09 09:02:59 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dbe3bace49035de793556148ed83d984 |
Change in substantial holding
|
2013-12-16 14:58:57 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e72ff3117abeb02d2b5c82a420a24396 |
Change of Director's Interest Notice
|
2013-12-16 15:23:21 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc6ecb05565e2595a959aaf8cf916185 |
Change of Director's Interest Notice
|
2013-12-19 11:14:09 |
Withdrawal of NTCELL pre-clinical study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fd817df26ac92a80ad3f12b61bb3723 |
|
2014-01-21 11:02:00 |
Executive change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b68a0ee0a3d4d707a0cc5ab241229c95 |
Company Administration - Other
|
2014-01-23 09:00:58 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a5f112f1db85ed6db5867bbb30e6dab |
Change in substantial holding
|
2014-01-29 10:42:38 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af561656aff81526576fb0cac8e51df6 |
Commitments Test Entity - Second Quarter Report
|
2014-01-29 10:44:42 |
Appendix 4C Cash Flow Report 31 December 2013 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30cf0fdea6d76bab2dfc10a85ef9d4a8 |
Commitments Test Entity - Second Quarter Report
|
2014-02-06 08:34:31 |
Appointment of NTCELL Program Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ee6a24988bc5cc129c10a14e07be717 |
Director Appointment/Resignation
|
2014-02-20 10:29:10 |
Statement on NTCELL Phase 1 Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f032ab2023c3040fdaedb6e2a3ee0e57 |
|
2014-02-25 16:19:15 |
Appendix 4D and Half Year Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/541d36e5d6ab325f8ba101e8c8dbeebc |
Half Year Directors' Statement
Half Year Directors' Report
|
2014-04-01 08:53:51 |
LCT restructures |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a87797e9d1e1fa054ef274e74333a003 |
Company Administration - Other
|
2014-04-01 10:57:56 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a42da93dc8edf6e87123445ef470304c |
Final Director's Interest Notice
|
2014-04-29 12:00:58 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9c90204a14f49b5609c94cbb3d252ac |
Commitments Test Entity - Third Quarter Report
|
2014-05-15 10:43:35 |
LCT to develop NTCELL independently |
1 |
https://app.sharelinktechnologies.com/announcement/asx/897da6f2a6f265390fa384370f26ce31 |
|
2014-06-23 09:59:56 |
LCT Parkinson's trial resumes patient recruitment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c222ca24696e5cc18f70d4982be03dac |
|
2014-06-25 10:51:50 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40134fc34ed40ef1838536e5a919115a |
Change of Director's Interest Notice
|
2014-07-08 10:43:39 |
Dr Ken Taylor appointed Chief Executive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8bf866d088b2d61f15212a902485644 |
Director Appointment/Resignation
|
2014-07-08 12:00:58 |
Chief Executive's Remuneration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f1268540714bd9672588b25ab740db6 |
Director Appointment/Resignation
|
2014-07-30 13:03:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d92b83eea34dd1ac7fcd52233706270c |
Commitments Test Entity - Fourth Quarter Report
|
2014-07-30 13:05:03 |
Appendix 4C Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09fd18c2477ee2f8a4a565fd585f4dad |
Commitments Test Entity - Fourth Quarter Report
|
2014-08-01 13:44:43 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26fc369d9cae4f5dcafd6c9e7a10d6a2 |
Change of Director's Interest Notice
|
2014-08-15 14:51:46 |
Appendix 4E and Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41aae04243effaf8179db3f1b4e503b1 |
Full Year Directors' Statement
Full Year Directors' Report
|
2014-08-15 14:55:53 |
Preliminary Final Report 30 June 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5bbfd8676081b56c297c9221327ed8f2 |
|
2014-08-18 11:50:43 |
Successful second implant of NTCELL for Parkinson's |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d12d360bd8c297bb93fdbcb3a2cd5b74 |
|
2014-09-16 16:39:37 |
2014 Annual General Meeting and Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aaac5e3bf7e62900a12ae308b4027bfd |
Notice of Meeting - Other
|
2014-09-23 10:16:14 |
LCT Appoints Scientific Advisors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ae972ef6c204575ffbe7f3d94953575 |
Company Administration - Other
|
2014-09-29 13:07:04 |
LCT collaborates to develop novel neurological treatments |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f9b09e57cf85712d70a23ada08ca67a |
|
2014-10-08 08:35:33 |
Completion of $3m placement and SPP announced |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ed38c8473104a3e40b97675d7a8d6f42 |
|
2014-10-08 08:53:51 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6061c277da119c660e90a77b5cc7147b |
|
2014-10-10 14:25:22 |
LCT JV secures funds to realise the potential of DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e99f09566163972befb3c72f99e06f7 |
Security holder details - Other
|
2014-10-10 14:31:30 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7344fa9921c7fc198bc6f4fc2d00e2a |
|
2014-10-14 13:26:25 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd03e1da5f7996bdde62bc05a434570a |
Change in substantial holding
|
2014-10-15 09:58:57 |
Share Purchase Plan Offer Terms and Conditions |
0 |
https://app.sharelinktechnologies.com/announcement/asx/feafc12013de1104e583c0d0b54f8728 |
|
2014-10-17 13:04:02 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05a7c6d8b21bd41830e8260c20653576 |
Full Year Directors' Statement
Full Year Directors' Report
|
2014-10-17 13:13:11 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79b5dc14d247a042b876dd5f59243259 |
Notice of Annual General Meeting
|
2014-10-28 13:19:17 |
LCT Share Purchase Plan extended to 28 November 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfc88426dfa8226443cb09c40e55a9be |
|
2014-10-28 14:38:32 |
Appendix 4C 30 Sep 2014 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f363136f69de61d616b92d52b0acc35 |
Commitments Test Entity - First Quarter Report
|
2014-11-03 08:57:53 |
Recruitment of all patients in Parkinson's trial completed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc4eec8b757640a21a7e48f9d8785e18 |
|
2014-11-18 11:32:31 |
Chairman's Address to 2014 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f39e3338a4332579618d9857423e9d7c |
Chairman's Address to Shareholders
|
2014-11-18 11:33:32 |
Chairman's Presentation to 2014 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5bc21d40f95ba3ad3498f7b8a18ab2c9 |
Chairman's Address to Shareholders
|
2014-11-18 11:36:35 |
CEO Presentation to 2014 AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55ea2cd98c8b35fac140833655bbc00d |
Chairman's Address to Shareholders
|
2014-11-18 12:21:20 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dcc72c5588f374946c768abff2e817e0 |
|
2014-12-04 12:44:43 |
LCT share purchase plan raises $1.08m |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00283644b3948b371a89278f08dcabce |
|
2014-12-08 10:44:42 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1adef5bf2fb61525ce1eaf59cfc78349 |
|
2014-12-08 10:47:46 |
Share Purchase Plan-Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c29fa23bc6539c75c275c11979c4feee |
|
2014-12-09 11:38:35 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ce1c7a49ba988c36af1ca9c8cf8806a |
|
2014-12-15 10:05:57 |
LCT completes patient implants in Parkinson's trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb7248d7de2db68cd6ce5f52d928a98e |
|
2015-01-19 13:07:06 |
Change of Registered Office Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d55d87b4b2af2bee8c835f58cf8a4a4 |
Details of Registered office address
|
2015-01-28 13:35:30 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1de4489e0fb9cc980688236b7cf35102 |
Commitments Test Entity - Second Quarter Report
|
2015-02-02 16:12:10 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d62a72b35076830701ca088ea2a029a |
|
2015-02-18 12:49:38 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89c3f974f86cd6425b7bdb02d035f8dd |
Half Year Directors' Statement
Half Year Directors' Report
|
2015-02-24 09:05:57 |
Professor Elliott steps down from executive position |
0 |
https://app.sharelinktechnologies.com/announcement/asx/683a061378e2158d96babd43572a27cf |
Director Appointment/Resignation
|
2015-03-05 15:45:37 |
LCT JV adopts new strategy for DIABECELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a8ff14e6b2b1bfa12568be09f6e2c10 |
|
2015-04-23 15:40:37 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a7005cfda5ef45f57b5a5f7e86b236a |
Commitments Test Entity - Third Quarter Report
|
2015-04-23 15:45:42 |
Commentary on Appendix 4C |
0 |
https://app.sharelinktechnologies.com/announcement/asx/945c09ad78b8e9d5abcd191700de6ecb |
|
2015-06-05 15:31:29 |
CEO Remuneration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8402c86b480f7b4b6824af476e85a9a |
Company Administration - Other
|
2015-06-12 16:28:23 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9033d60abb6a206b0df09d44499c5b06 |
|
2015-06-15 08:54:10 |
NTCELL Clinical Study in Parkinson's Meets Endpoints |
1 |
https://app.sharelinktechnologies.com/announcement/asx/adcece28628c577b2fc894719e558afa |
|
2015-06-15 13:23:22 |
NTCELL Clinical Study - Investor Conf. Call Time Correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/654088c58e71ea2850cee3b7ce0bd930 |
Company Administration - Other
|
2015-06-16 09:10:03 |
Parkinson's Congress NTCELL Poster Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db899c9482d0b997f1970536fc9b82d8 |
|
2015-06-18 09:22:18 |
LCT hosts conference call on Clinical Study in Parkinson's |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a27f8b5739a5b4e3febdc12b0341a2e |
|
2015-06-26 14:46:42 |
Update to DIABECELL development strategy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5a19209ffb997d5e595bc68156f288e |
Company Administration - Other
|
2015-07-14 14:07:05 |
Proposed grant of options to Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5c31e22b88916d9502b7810678961c4 |
Company Administration - Other
|
2015-07-27 14:21:16 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce5b866b923314e8f51f8e20172428c4 |
Commitments Test Entity - Fourth Quarter Report
|
2015-07-29 15:50:44 |
Response to ASX aware letter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8503fc429c847e586e53017ac0ce6634 |
|
2015-08-05 08:30:25 |
Living Insights Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58a85eb9c337b637f0af5f73ba3f9069 |
|
2015-08-18 11:54:47 |
LCT planning to resume control of NTCELL manufacture |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6eb1a125b94741fc4794b095409a7d8 |
|
2015-08-19 11:24:18 |
Appendix 4E and Financial Statements YE 30 June 2015 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d0300073bdbc6823a47190891a20825 |
Full Year Directors' Statement
Full Year Directors' Report
|
2015-08-19 11:28:26 |
Preliminary Final Report 30 June 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cd3d7269b40d8e2add8ede3c0f42cf6 |
|
2015-08-28 11:42:07 |
LCT to receive Callaghan Innovation Growth Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c14568e014926db0d26c63bf48ed0c0 |
Company Administration - Other
|
2015-09-03 09:46:44 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f675a9d6059ef98f81e5c2674f5d6556 |
Change of Director's Interest Notice
|
2015-09-15 10:12:11 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/482ac51fbef9af790717fead98f5eab8 |
Change of Director's Interest Notice
|
2015-10-09 17:19:16 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4339faf03dc61b316a6eb1cebd10423b |
Notice of Annual General Meeting
|
2015-10-09 17:23:22 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/154b592792b8bd78e91f939c9fa8bc20 |
Full Year Directors' Statement
Full Year Directors' Report
|
2015-10-14 09:15:13 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e51468f156ea41b7e5c01bc6182657ef |
Commitments Test Entity - First Quarter Report
|
2015-10-14 09:18:16 |
Commentary on Appendix 4C - 30 September 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2faac7d457bbeb41a1d9de686996f0b |
Commitments Test Entity - First Quarter Report
|
2015-10-27 14:45:39 |
NTCELL - Parkinson's trial 42 week result |
1 |
https://app.sharelinktechnologies.com/announcement/asx/017ef35c9350300b57e206d736c02941 |
|
2015-11-11 13:58:38 |
FY15 Annual Report - Rectification to Auditor's Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bfbb7cf587d89d6680cc68f9dfe9195 |
|
2015-11-12 09:55:49 |
Minister authorises Phase IIb Parkinson's study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e286b99d54bd48a4be3dcf75b482122c |
|
2015-11-12 11:49:46 |
CEO Presentation to Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c59d9a1fa8056fd614bea02612836f50 |
Chairman's Address to Shareholders
|
2015-11-13 14:39:37 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c24f792839d7f34d42701af5ca29abfe |
|
2015-11-16 09:47:42 |
Update on clinical trials of encapsulated pig islets |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4130ce4d623df1b9b16b9aefcb47f833 |
|
2015-11-18 12:13:11 |
Special CEO Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d4ea6b552e7469709465a367817e24e |
|
2015-12-02 16:05:57 |
LCT secures supply of NTCELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3edea8abbf714bf66e1ad67497fbb426 |
|
2015-12-18 15:01:50 |
LCT complies with ASIC infringement notice |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab85a06d256dc184472d61d142e73227 |
|
2016-01-05 09:44:39 |
Change of Company Secretary, Registered Office Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8710888c29e7699981f8ec90401ad9d4 |
Details of Registered office address
Company Secretary Appointment/Resignation
|
2016-01-12 14:07:01 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b75bb65b73e773b0aa90508f3aac9878 |
Commitments Test Entity - Second Quarter Report
|
2016-01-12 14:07:02 |
Commentary on Appendix 4C - 31 December 2015 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76043720bf41c47e278aa72046ae46d4 |
Commitments Test Entity - Second Quarter Report
|
2016-01-27 09:23:22 |
NTCELL reverses the progression of Parkinsons disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/796a7a2cd78175eb475e4c2a3b8a536d |
|
2016-02-03 13:57:52 |
LCT receives ethics approval for Phase IIb Parkinsons trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8769684867f8a7cc90480860304dfa07 |
|
2016-02-17 09:38:36 |
LCT completes $2.8m private placement and announces SPP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4281cddc8946a1a06360b6dbddbc2d13 |
|
2016-02-18 11:51:50 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5afd396c2999ed8cfb48e3d4e2b5e5e6 |
|
2016-02-18 11:54:53 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bda57260ae6b6025eb4fe10eaaf26d50 |
|
2016-02-19 14:28:26 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee6aa02aae6be247040fddfef3889b74 |
Becoming a substantial holder
|
2016-02-23 16:48:44 |
Dispatch of Share Purchase Plan Offer Documents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3012b9969a57ccf96c687525a9c3f2dc |
Company Administration - Other
|
2016-02-26 13:19:12 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f9c94f65baef2439c746691bae62cb1 |
Half Year Directors' Statement
Half Year Directors' Report
|
2016-03-09 08:38:35 |
Extension of SPP Closing Date to 29 March 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4660f58d05fd12bfc936e344d05d963f |
|
2016-03-24 10:08:01 |
LCT starts Phase IIb clinical trial of NTCELL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e621e584350a65935200efb5ee2a1db6 |
|
2016-04-04 10:27:25 |
LCT share purchase plan raises $0.5m |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d65c499485309c28179bc14d2a44c432 |
|
2016-04-06 15:29:27 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/360b9bda6416f7072223c4e7071a4964 |
|
2016-04-07 11:35:32 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b2e6f3137dd242ef1ec444698213822 |
Ceasing to be a substantial holder
|
2016-04-08 12:25:23 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d6b442df2748c9b7d89c4042b662215 |
Change in substantial holding
|
2016-04-14 16:04:58 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e293630fd83e633084c595e42c1d933 |
Commitments Test Entity - Third Quarter Report
|
2016-04-21 09:04:01 |
LCT successfully completes funding round |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50a8fe4b9df6bf738044d33477d15539 |
|
2016-04-21 10:01:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c36efa0412805bc65084ecf8cdc4e5c |
|
2016-04-21 10:07:03 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/233fa5362802fd7a430df02a1fd3446a |
|
2016-05-10 14:12:11 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37ffa18c4572f367c30fe75dea94804b |
|
2016-05-16 16:34:31 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afd89127b747b4b7f149f4c172f42450 |
|
2016-06-07 14:16:13 |
NTCELL demonstrates continued reversal of Parkinsons |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0ce68e0529cd348b667e94df06d9c0f0 |
|
2016-06-08 16:49:47 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d2c2d97c0eb3580136ac484b012f5bf |
|
2016-06-22 17:21:19 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fe936651fd00ce46729f92212bd1fd85 |
|
2016-06-23 15:17:13 |
NTCELL Trial Results to be Presented in Berlin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c112f705d792d4186bc07a8c36723ab8 |
|
2016-07-26 09:01:59 |
Living Insights Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f8ac3a839444e734abbb4116934a4b5 |
Letter to Shareholders - Other
|
2016-07-28 09:44:43 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7aae22528392332701bf5fbf6f5b5e8c |
Commitments Test Entity - Fourth Quarter Report
|
2016-08-17 13:28:22 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a14c4cbb3663aacc4693e7f3409c3c0c |
|
2016-08-22 16:23:20 |
LCT's joint venture focuses on US developments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d38593fb90e25f69a24fb3ddbd64bd5a |
|
2016-08-24 16:09:57 |
Preliminary Final Report and Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d9627c086ac66f90cc5aad4350e29a8 |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-08-25 11:07:06 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6d1fae18a3532c3e0a79580b57e633f |
|
2016-09-01 08:22:19 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c67c07b946605d703afd29883663229a |
|
2016-09-20 14:44:40 |
2016 Annual General Meeting and Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1697e3bb1f3d3d0dc758479909fd9ca1 |
Notice of Meeting - Other
Company Administration - Other
|
2016-10-05 09:10:07 |
Group 1 patients successfully treated in Parkinsons trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/decae569342f9af72920f1b190a793a9 |
|
2016-10-17 15:33:31 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19acb37cd23c4cfe75e4312129a91d93 |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-10-17 15:37:35 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e13e35f12364ebb5191a99b3e8c47db |
Notice of Annual General Meeting
|
2016-10-20 09:36:32 |
Appendix 4C Quarterly Cash Flow Report 30 September 2016 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72a2ddef430918d7badd50cc8340562c |
Commitments Test Entity - First Quarter Report
|
2016-11-11 08:43:41 |
Approval granted for group 2 in Parkinsons trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06ee9f8dfb538b2b53e78f341d43d5f6 |
|
2016-11-16 10:18:16 |
Chairman and CEO Presentation to Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5c3b5121c958086fef766196488d5f0 |
Chairman's Address to Shareholders
|
2016-11-16 12:45:43 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5161677dccebd8abe872a5728df56d4c |
|
2016-11-24 09:34:30 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1338f7b2b3f11b3c440184842dde8f10 |
|
2016-11-28 10:15:10 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be5c551a33bf5db6dd76735fb91615fd |
Suspension from Official Quotation
|
2016-11-30 10:27:15 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a59eef26b4a590d295e951c27b391ad |
Reinstatement to Official Quotation
|
2016-11-30 10:27:36 |
Private Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9411e1218d0744a7776426dbd931b4ae |
|
2016-12-01 15:56:52 |
Living Insights Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afdc8239c3648700f3e0c27a1f5988e9 |
|
2016-12-06 15:44:43 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5db130cc006df259ab23543a20533336 |
|
2016-12-06 15:47:44 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ddcca75bf761734d9835772aef0cae0d |
|
2016-12-07 13:27:24 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/231a9726b64bf73866fa1341232efec1 |
Becoming a substantial holder
|
2016-12-14 17:08:05 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70f1e2df0dd70ea5de93330ea396b4f8 |
Ceasing to be a substantial holder
|
2016-12-21 16:35:33 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44cd6ef3405afde0c2b0c57feaa0d831 |
|
2016-12-21 16:36:35 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bab76d52bae0782b91ec2fac801f65df |
|
2016-12-22 12:18:11 |
Group 2 Parkinsons trial patients treatment completed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d75ffa5a9784f6d1f3d65fe08ef9250 |
|
2017-01-11 12:38:30 |
US choroid plexus cells patent application published |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc1fa11318d42a67044711d9da166faa |
|
2017-01-20 08:27:05 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/960129c57e461f2854b11085f7028342 |
Commitments Test Entity - Second Quarter Report
|
2017-02-08 10:16:11 |
Approval granted for group 3 in Parkinsons trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae84c23ebf8f14e997fd4f338c74cc7f |
|
2017-02-22 11:22:16 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fdcc3dfdce7136fd3de0f46b7dfa0251 |
Half Year Directors' Statement
Half Year Directors' Report
|
2017-02-28 09:52:46 |
Living Insights Newsletter February 2017 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d583d9a21b7eee959f6cae30e167be5 |
|
2017-02-28 14:40:35 |
CEO Presentation - Halting Parkinsons with cell therapy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2d5fd3d14fddcba04df8e0311a7cc99 |
|
2017-03-13 12:32:32 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3968d16f2a1de8bf28d58e59f27d7407 |
Change of Director's Interest Notice
|
2017-03-14 15:02:00 |
Amended Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed1ae4a1bf6bb9770d35ffdc81ff07da |
Change of Director's Interest Notice
|
2017-04-26 10:31:26 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cfa84c7a82ee93ed5888d14dc7a7e4b7 |
Commitments Test Entity - Third Quarter Report
|
2017-05-01 08:36:34 |
Treatment completed for all patients in Parkinsons trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5f39c97d2e697784bfbb045157c0ad2 |
|
2017-05-16 11:03:00 |
LCT collaborates with CBR to extend product pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/708a3a5c449d15f99924a1a840ed513c |
|
2017-06-06 14:37:30 |
NTCELL continues to halt progression of Parkinson's disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f81c86cd4b9173b2b17fe6d4650015ad |
|
2017-06-30 13:22:21 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62b3772d5d37e7c56afc5566713c6912 |
|
2017-06-30 13:24:22 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bba11aab9ae18ae59bea67ea96edf96 |
|
2017-07-20 14:44:41 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b6e20ce1f8fa8dc143831d642e766de |
Commitments Test Entity - Fourth Quarter Report
|
2017-07-24 09:01:00 |
Living Insights Newsletter July 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e48ecee49113347f74354744009b3c60 |
|
2017-08-23 12:44:38 |
Preliminary Final Report and Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4764e59aee7461d33d0179a6d28c21c |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-08-29 10:10:08 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d241278a219d756b9a84cd7090307585 |
|
2017-09-19 10:09:07 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b8575ad8accbfc58d98d563681dcfa9 |
|
2017-09-19 10:14:12 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c668bd7972234db7584fc0f92ce2ce8b |
|
2017-09-22 15:54:52 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a1c280dac70d165c68645c79cf36103 |
|
2017-09-22 15:59:57 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2ac3a018a55e47696126bdfe9625333 |
|
2017-10-03 10:19:16 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5eba144376b560beff3882a5c351ab5 |
|
2017-10-04 13:20:18 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6675ac18290769a881e887182d7d527a |
|
2017-10-04 13:23:22 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c996cf8e5a38c60480c6dce0c17c7a1e |
|
2017-10-10 09:20:18 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d7c9680384d2128ea2454aa4b82a029 |
|
2017-10-10 09:22:21 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e6cec0e8ce732ea3bc2527241085895 |
|
2017-10-16 12:06:02 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dea2b52ec185b1e6a31a3e93960b0123 |
Notice of Annual General Meeting
|
2017-10-16 12:08:06 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9739a918e2461499e712835798121a57 |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-10-18 14:51:49 |
Appendix 4C Quarterly Cash Flow Report 30 September 2017 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d9511b9540bc5c976ce6b6f0149ae356 |
Commitments Test Entity - First Quarter Report
|
2017-10-27 15:49:48 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf0b9ad02d7fa4ca0715f6e5edb453f6 |
|
2017-10-27 15:52:49 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e90ef314e93fdd356345f6049f89ed3 |
|
2017-11-07 13:12:10 |
LCT files pericyte protective agent provisional patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b544aa8b8d1006dcd8a89a0248039e9a |
|
2017-11-09 09:21:14 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/71d73bb74d03442043bee3ec4d82b48c |
|
2017-11-10 09:40:25 |
Results of LCT Parkinsons trial require further analysis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b98fc18e2b8e11994fe652449c446ad9 |
|
2017-11-13 08:28:18 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e688f81eb478b5b2a1696c43c938f332 |
Change in substantial holding
|
2017-11-15 11:49:45 |
Chairman's Address to the 2017 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9884a5cc3a8ff7471a0fa217f8c9589 |
Chairman's Address to Shareholders
|
2017-11-15 11:52:50 |
CEO Presentation to the 2017 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fcf7912f85dd20b4fbebd04d009d71f |
Chairman's Address - Other
|
2017-11-15 15:58:57 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c87f0ed2e46ee90b3bb19dacce324753 |
|
2017-12-21 08:29:09 |
NTCELL and Parkinson's Clinical Trial Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63696692829d31fd4884c60e6ac119de |
|
2018-01-24 10:23:20 |
Appendix 4C - Quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96416c50e3b42f92a9718b722a606483 |
Commitments Test Entity - Second Quarter Report
|
2018-01-25 11:04:00 |
LCT to sell JV Shares and receive DIABECELL licence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82ca8afad5f230b83bc35b91c5fe06d6 |
Security holder details - Other
|
2018-02-22 16:42:40 |
Half Yearly Report and Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/515a6598766031d463deb5a19f951d73 |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-04-11 09:56:46 |
LCT Strategy Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f08a1b807b7d62891c8495d5b9001163 |
Company Administration - Other
|
2018-04-26 09:30:28 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63f2e08048d87ae7fefdbc115c566ad1 |
Commitments Test Entity - Third Quarter Report
|
2018-05-15 08:22:38 |
NTCELL and Parkinsons trial update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7acea67bf515fd9ec6a19cecb7d0d459 |
|
2018-05-16 12:20:19 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c90519e6b6ca8535f186baf705e8b08b |
Ceasing to be a substantial holder
|
2018-07-26 19:14:13 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50e3b133ae86fd073b46a223dd39b909 |
Commitments Test Entity - Fourth Quarter Report
|
2018-08-13 11:40:38 |
Living Insights Newsletter August 2018 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00192b92358c1a10676c5b8144818224 |
|
2018-08-30 18:11:08 |
Preliminary Final Report and 2018 Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e6f84002f9a67f71b81ab8c80e3cc93 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-08-30 18:15:12 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f382e826904003c259312ccd415ddeb9 |
|
2018-08-30 18:19:16 |
Updated Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe4aea79ac764c573f3a1fefcd399fc7 |
|
2018-08-30 18:24:22 |
Company Secretary Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73d003a297ee7b56676bab169f88944b |
Company Secretary Appointment/Resignation
|
2018-08-31 09:08:05 |
LCT Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7a4b462a6a5523c15c20a68e5530f1e |
Director Appointment/Resignation
|
2018-08-31 09:34:20 |
Appendix 3Z - R Austin |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29f10cdd07f10b7862ea6effc9727e65 |
Final Director's Interest Notice
|
2018-08-31 09:55:50 |
Appendix 3X - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2b58ef8c3614685a6e4ab0b791ef74a |
Initial Director's Interest Notice
|
2018-09-05 09:54:50 |
Change of Director's Interest Notice - R Elliott |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff7e56fecbbf148702a919617a49c953 |
Change of Director's Interest Notice
|
2018-10-15 11:50:47 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a40d7d9ed4a5be82dfc145d83db720d |
Notice of Annual General Meeting
|
2018-10-15 11:52:50 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92afa753248d72397ac95332279e0a7d |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-10-19 14:13:10 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e82825fc54bd39f38e5766b109d8e3e |
|
2018-10-26 14:12:09 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dfe3851c9a3096a6d3049b5c80b63b71 |
Commitments Test Entity - First Quarter Report
|
2018-11-02 09:20:16 |
NTCELL Parkinsons trial patient data at 18 months |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2acc15dc8e1dfcdbb940c34d8dd5dec1 |
|
2018-11-07 16:24:22 |
Change of Director's Interest Notice - R Elliott |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53d2e79e572e5b9e10c0a72289124541 |
Change of Director's Interest Notice
|
2018-11-15 11:41:38 |
Chairman's Address to the 2018 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba64f367b3583df9da76a99a9de3e5e8 |
Chairman's Address to Shareholders
|
2018-11-15 11:47:43 |
CEO Presentation to the 2018 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d19b31bf7e29c59fe6909256cae1d9f4 |
|
2018-11-15 14:15:12 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/936180cc95b504ee0a2a4386ae25f16d |
|
2018-12-13 16:54:53 |
Appendix 3B - Unquoted options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe059f6dfbb809b897f6a172a9e92dec |
|
2018-12-13 17:08:07 |
Change of Director's Interest Notice - B Tuch |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36c295612a6a135784df60e0aa2ed13a |
Change of Director's Interest Notice
|
2018-12-13 17:10:09 |
Change of Director's Interest Notice - R Elliott |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3533090f6bc22d6fefc5a8728e3f285 |
Change of Director's Interest Notice
|
2018-12-13 17:11:09 |
Change of Director's Interest Notice - L Hunter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/321770b74f503cec5434e5ed79431156 |
Change of Director's Interest Notice
|
2018-12-13 17:12:11 |
Change of Director's Interest Notice - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8cf4861a4579f7b7fe5bc1c0ba67240 |
Change of Director's Interest Notice
|
2018-12-13 17:15:13 |
Change of Director's Interest Notice - R Willcocks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c291500416f68d1b1b55c59b8c25c433 |
Change of Director's Interest Notice
|
2019-01-21 09:29:25 |
NTCELL Phase I IIa Parkinson's trial update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be34da2f1d9256420692bc642eee4033 |
|
2019-01-30 11:27:26 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16c418f5ec92d5aa97a971f82bbfe954 |
Commitments Test Entity - Second Quarter Report
|
2019-02-19 08:22:15 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e7eab992e58c00addd5da9851e9a3466 |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-03-01 08:25:33 |
Living Insights Newsletter February 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/707b6a294624cbcb1fb050534a2ad1b2 |
|
2019-03-08 08:43:38 |
CEO presentation to Phar East conference, Singapore |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe8da91883c4071ba62901adc83e7c83 |
|
2019-04-15 14:50:47 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc058c21bef147e845dd16607999ccf4 |
Commitments Test Entity - Third Quarter Report
|
2019-05-07 08:47:45 |
LCT board changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2c915fd809f418baac93b08d74fd337 |
Director Appointment/Resignation
|
2019-05-13 09:21:12 |
NTCELL Parkinsons trial patient data 2 years after implant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f08fc8d20ee230d9d6e1291cb5f731f8 |
|
2019-05-16 16:43:41 |
Appendix 3X - Carolyn Sue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed685b59bb26fce1fa0c14ffc9716084 |
Initial Director's Interest Notice
|
2019-07-23 17:15:10 |
NTCELL Parkinsons trial 2 year data analysis shows success |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b49ae8c7ed2ae0c9202d22f0b027bc6c |
|
2019-07-26 11:36:32 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a4f8dbe671e5e1d5ade8fc6d3e55d3e8 |
Commitments Test Entity - Fourth Quarter Report
|
2019-08-29 16:50:44 |
Preliminary Final Report and 2019 Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f3f4d9e20880dd3b8b92e957a1139815 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-09-09 15:15:09 |
Living Insights Newsletter September 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8834514c125865521821622cc5b941c7 |
|
2019-09-10 11:56:53 |
Notice received under s203D & s249N of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67d271d9704e3c8696aa0a7f4e9e0e88 |
Notice of Meeting - Other
|
2019-09-17 09:35:33 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c1777f8e5f6220ef3de7e450377b3fcd |
|
2019-09-19 08:22:00 |
LCT to benefit from Semma Therapeutics acquisition by Vertex |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fafad793247b1227559061cd80d88b4f |
|
2019-09-27 13:06:04 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54fd24096de2b237420cb1be4c186d48 |
Becoming a substantial holder
|
2019-10-04 12:36:33 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/681ea87d7c9f9cfeea65457f734b1a42 |
Notice of Annual General Meeting
|
2019-10-04 12:40:38 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4edcc79e3248021895d29b96ae954018 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-10-04 12:44:41 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56d7bc94e527ec02078cb2fc227258e0 |
|
2019-10-16 08:54:49 |
LCT extends cash runway with receipt from Vertex acquisition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb7c394072ebd08cde94cc31df0e2e5d |
|
2019-10-24 09:33:30 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa0317a7b42bab29412fd2a7786aab5e |
Commitments Test Entity - First Quarter Report
|
2019-11-07 11:51:43 |
Chairman's Address to the 2019 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ae2609e0e973669f060e342819869fa |
Chairman's Address to Shareholders
|
2019-11-07 11:56:53 |
CEO's presentation to AGM and market update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b824bb15cecd26c677e403e167750326 |
|
2019-11-07 14:15:13 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1052216e75e3e1a85b964599a86e826 |
|
2019-11-08 08:46:44 |
Dr Andrew Kelly joins LCT board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01906ebc5efb1be1fbb5057e2029c0c4 |
Director Appointment/Resignation
|
2019-11-11 16:19:17 |
Appendix 3Z - L Hunter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f949372461ab5737ca8167e9d874ae2 |
Final Director's Interest Notice
|
2019-11-11 16:24:20 |
Appendix 3X - A Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a75c28f05f74e95e2aba536062c61a9 |
Initial Director's Interest Notice
|
2019-12-06 16:16:13 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cb7c01692de8ed8d45e5b09cdab0a40 |
|
2019-12-06 16:22:20 |
Change of Director's Interest Notice - C Sue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cbf9d6a6513cd08b3c4d0c081f20eca |
Change of Director's Interest Notice
|
2019-12-06 16:22:21 |
Change of Director's Interest Notice - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e45a7321821ccd0a12b909f00d463869 |
Change of Director's Interest Notice
|
2019-12-09 09:41:39 |
Response to Appendix 3Y Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/979e2724c0db5df201f4e25e7fd8e98a |
|
2019-12-20 16:43:41 |
Resignation of Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04da25a4bff7c11888ca846677a45294 |
Company Secretary Appointment/Resignation
|
2020-01-30 15:26:20 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/180994902f1c3a00fcd03bd7e70f4c82 |
Commitments Test Entity - Second Quarter Report
|
2020-02-27 18:41:32 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3a9526cd209dc80fa5d31336ee0b14e |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-04-17 14:55:40 |
LCT Covid-19 Business Impact Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de88813edb7dce36838b5c7ed083f5aa |
|
2020-04-29 14:39:36 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1030b01e5d2729d4a691f3e1567398e0 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-07-03 13:31:29 |
LCT Newsletter - July 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cd9c1639c795d1536927e81fdca597e |
|
2020-07-08 15:03:00 |
Change of Director's Interest Notice - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/354d969b312186a393945fb832929f52 |
Change of Director's Interest Notice
|
2020-07-13 09:32:30 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83f81376107438b300b2c4cc892f4e1d |
|
2020-07-30 10:07:04 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/461cf43532d2f91afbd3ee7bc4cd401f |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2020-07-30 14:53:49 |
Amended Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a08d863b705ceebc5943ff48cc96626a |
Commitments Test Entity - Fourth Quarter Report
|
2020-08-21 16:33:30 |
LCT founder Sir Robert Elliott dies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd09117aecafca5ba522fa6d933fe8cd |
Security holder details - Other
Final Director's Interest Notice
Company Administration - Other
|
2020-08-31 12:43:37 |
Preliminary Final Report and 2020 Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dfc2416cf050e81917455a32fc881b46 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-09-18 14:54:50 |
Notification of Change of Auditor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ad482298e0d64651d64fd4046d062de |
Company Administration - Other
|
2020-10-19 17:24:13 |
2020 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b0bea203e417355c04d52829380eb5b |
Notice of Annual General Meeting
|
2020-10-19 17:29:17 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e0b2572a7cbbe77a6a00ff3f8400a74 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-10-19 17:29:19 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0dfb85538207f2f5d4c174b8b09d14e6 |
|
2020-10-28 17:24:21 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6da83fa5d1f8ecd5384325761746865d |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-11-19 13:38:28 |
Chairman's Address to the 2020 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2ef6068a168884eafbd8d0fc06a61aa |
Chairman's Address to Shareholders
|
2020-11-19 13:43:37 |
CEO's presentation to AGM and market update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45eb5625adaaf3f72594cff023ba1b11 |
Chairman's Address - Other
|
2020-11-19 17:15:12 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ccc0dff70d430b02dec2e14aaf2bc3c |
|
2020-11-27 13:40:38 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb068329bf1b62d61469833d25dac0f6 |
Becoming a substantial holder
|
2021-01-13 16:04:01 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21b37c9ad4d96ec28bd054b5dfa7e79f |
Change in substantial holding
|
2021-01-19 09:44:40 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07f63a3015026346e22966fa1e7c0408 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-01-19 10:28:25 |
Correction Notice - Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/211eca635778de1c0787f3b618676eef |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-01-25 11:05:57 |
LCT CEO Dr Ken Taylor signals intention to retire |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5cef3223315b450dd9a204425ac47f60 |
Director Appointment/Resignation
|
2021-01-28 09:00:58 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b21204757079fc4e2e9b9fabe47c2281 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-02-12 09:43:41 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b9f853b8c6dfea4ea5e5ee8bf9870c8 |
|
2021-02-15 15:47:43 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a29d9992d6f77330220a87a293958249 |
Change in substantial holding
|
2021-02-17 11:50:46 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b81d59d462dc1d0f37303cd2c54d52a |
Change in substantial holding
|
2021-02-25 15:47:40 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fe3c34513ca96816fba900bf90fdfac9 |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-03-29 08:56:54 |
LCT exits peptide projects |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fec328c8039dee6e4c7227a894ac4000 |
|
2021-04-27 16:56:54 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78205022cc6cdb7bda173e25b4e1399c |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-06-10 14:21:19 |
Business Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61c97e8c988f83ed282fce51e9307ad1 |
|
2021-07-02 13:57:57 |
Notification of cessation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/313cf13aa9b567b2b8d2537dc1d06393 |
Appendix 3H (Notification of cessation of securities)
|
2021-07-02 14:02:00 |
Change of Director's Interest Notice - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94c54b9b2a03b434b5ee8fae96e48b5b |
Change of Director's Interest Notice
|
2021-07-02 17:18:16 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15896b2d863840d522d0f21cada7dd31 |
|
2021-07-16 08:56:54 |
LCT Interim CEO Appointed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd2a69cc833b92e2c499cc931f833109 |
Director Appointment/Resignation
|
2021-07-19 09:12:10 |
Appendix 3Z - K Taylor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ea15af482b098729a1f3e36f8865c98 |
Final Director's Interest Notice
|
2021-07-30 14:04:02 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32ff805af7cffea86db11ee5fec51d3d |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-08-16 12:50:47 |
Business Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96326f26a00c8abed564334c6efe34e0 |
Company Administration - Other
|
2021-08-31 09:48:45 |
Preliminary Final Report and 2021 Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/52405a6006c2b64e11483fac8bd491a6 |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-09-03 13:24:23 |
Notification of cessation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81a8b5c66d34b07cdc56d9f9ff953384 |
Appendix 3H (Notification of cessation of securities)
|
2021-10-08 11:55:53 |
2021 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b36fb0733875abe7bcb55309fca890e |
Notice of Annual General Meeting
|
2021-10-08 11:58:55 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed054e836fe5e6b6405f7ee1dc8a5f7d |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-10-08 11:59:56 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0304d36435893dd7eb1caa630123a60a |
|
2021-10-15 09:54:51 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89fa0e85610785815838556344127eb5 |
|
2021-10-15 10:01:59 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6f1004383d3c01d4271e0cb76251ddd |
|
2021-10-19 09:32:07 |
Secures Funds for 3rd Trial of NTCELL in Parkinson Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/097b07b845b94f6ae723112035672d0c |
|
2021-10-19 09:32:21 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5846d21f6a46f736bf334f43c30ad8b3 |
|
2021-10-19 09:32:25 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/862d6d9d7451e7f582752f689b2ecb47 |
|
2021-10-20 11:40:38 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64d5f5d0a957295fb3682d51634b504a |
Appendix 2A (Application for Quotation of Securities
|
2021-10-26 11:59:57 |
LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/271f1bfd3195dd15c55ffec055dd42ce |
|
2021-10-28 10:21:19 |
Notice of General Meeting/ Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ccb2da6ebb2cf90542aaa4bcdbe0222 |
Notice of General Meeting
|
2021-10-29 09:06:03 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c61143418a8a1c26f17907e676b4219b |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-11-08 08:36:29 |
LCT Advises Price Change for Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/069e7943c870ea1d5f232a0c2d2b906f |
|
2021-11-09 14:35:33 |
LCT Receives New Zealand R&D Tax Credit |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b545d4fa68beaeee81be5f241da10e2 |
Company Administration - Other
|
2021-11-11 13:59:58 |
Chairman's Address to the 2021 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3d9116b4c8f4570cfa56f20d111bebd |
Chairman's Address to Shareholders
|
2021-11-11 14:01:58 |
CEO's presentation to AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ecfd4d54df46ee3686682022af2284d |
|
2021-11-11 15:38:36 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a14efea184a25666d4443bb2473f26ee |
|
2021-11-15 09:31:25 |
LCT- Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4573427d8a9f7093672959a665d1236 |
|
2021-11-15 09:35:27 |
Prospectus- Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/043651532c926c2fd13aee36d3dfca4f |
|
2021-11-15 09:44:30 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c7aa3a80742f7f6fa6fe8d0a053bcdd |
|
2021-11-15 17:03:53 |
Update - Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bca6916926e0ecb0fa7261daabc376de |
|
2021-11-23 08:44:42 |
Non-Renounceable Rights Issue Opens |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a21199cc24650797130d77250ea13c6d |
|
2021-11-29 13:30:19 |
Chairman's Address to the General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/395023e28bacdea7caa417fe89fcf195 |
Chairman's Address to Shareholders
|
2021-11-29 13:45:41 |
Chairman Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11bd73423e9d83b0211ce5e3ab597e28 |
Chairman's Address to Shareholders
|
2021-11-29 15:29:26 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e75bba2d28f3fb0477c0192033801aa2 |
|
2021-11-29 15:39:37 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92bb819f03c4828697db3f68d9825fa9 |
|
2021-11-29 15:49:35 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e72728a5d78079c9a51a2a106fc626c |
|
2021-12-01 11:32:17 |
Appendix 2A- Issue of shares and Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ba2dce28a38c88a2581a13ec2f1523f |
Appendix 2A (Application for Quotation of Securities
|
2021-12-09 10:01:57 |
Extension of Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cea6fb81e0b254ed1030de5e750c4141 |
|
2021-12-09 17:22:28 |
Update - Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1200302884309fe335e74c02a0e022ca |
|
2021-12-13 09:01:59 |
LCT to Issue Compensation Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1395368dd6853ca0b5ce43d4227fdb99 |
|
2021-12-13 09:06:04 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e097b71959f824bf08243a30a4e181a |
|
2021-12-13 09:09:07 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f0019383ae8633875652ddcba48d073 |
|
2021-12-13 15:05:02 |
LCT Appoints COO to Establish NTCELL Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d337fa8902290af2009df971cf22ea3b |
Company Administration - Other
|
2021-12-14 10:00:58 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4465b02b5814bababc25dc53f7221b4d |
Appendix 2A (Application for Quotation of Securities
|
2021-12-15 10:27:24 |
Notification of cessation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0ab23557f7c4056b6c9a2d52f825987 |
Appendix 3H (Notification of cessation of securities)
|
2021-12-21 14:24:15 |
Update - Appendix 2A- Issue of shares and Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e861c0917200eb5d7e6b15272485bab9 |
Appendix 2A (Application for Quotation of Securities
|
2021-12-29 07:58:32 |
Results of Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b867127fa84ed0a9d45991d4f494e5e |
|
2021-12-29 08:43:42 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81cc218d257907a3e8ebfdec2f68e309 |
Appendix 2A (Application for Quotation of Securities
|
2021-12-29 15:39:37 |
Update - Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdcafb7781dac87f2d177772f2da2c90 |
Appendix 2A (Application for Quotation of Securities
|
2022-01-24 09:49:46 |
LCT Signs Service Agreement with NZeno |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b48a93cf20c948fe7e3256c7711e240 |
|
2022-01-31 09:13:00 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0dd14cad183ad4010230069eead83a80 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-02-25 14:56:54 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ebaf2c9302b6ccdbdeba41e982f7250d |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-02-28 09:54:53 |
LCT Interim CEO Term Extended as NTCELL Advances |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e376087abff5fa238463bf9b051f5a3c |
Company Administration - Other
|
2022-02-28 12:11:09 |
Change of Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2d2384332d3cddd67de669c1b1c11b3 |
Details of Company Address
Details of Registered office address
|
2022-03-04 15:50:49 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5402ae43827faf6e5349e8bdc9d50f30 |
|
2022-03-10 11:06:03 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d6aae48201c5815e5e2b633131131e1 |
|
2022-03-21 13:27:21 |
Funding Update-LCT Advancing NTCELL with Investor Backing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/532f0a9c58fe3065eae58724494c492c |
|
2022-03-25 11:36:34 |
Notice of General Meeting/ Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7bace2379bb6420efda4f1dba996e2f |
Notice of General Meeting
|
2022-03-30 09:01:57 |
LCT signs Research Agreement with UTS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e96745ce7d26857ee4fcb8712c70c7d |
|
2022-04-28 11:50:49 |
Chairman's Address to the General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdfe6dee1a073a4f123932da2cbd56fe |
Chairman's Address to Shareholders
|
2022-04-28 12:01:57 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72b851e7221582461c6374d45a8f29f2 |
|
2022-04-28 14:03:02 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8e392eff7ba5eedbbd9dcb04a3e7dbd |
|
2022-04-28 16:03:00 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c72e8141a5e721be1f3749871b77c7f |
|
2022-04-28 16:10:08 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f64241212b7b5d0b879f4441804faa9 |
|
2022-04-29 15:40:37 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e9665b16638c5f6fd44b79a1138ce45 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-05-02 11:57:56 |
LCT Newsletter - May 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7170b8e74a37d4451515a09cbc0b05a2 |
|
2022-05-03 15:27:25 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d096a2fd3fcd1e7246cd995926ad43d4 |
Appendix 2A (Application for Quotation of Securities
|
2022-05-23 08:44:42 |
Artificial Intelligence to advance NTCELL Production |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abc334eaa93e64884a4b690d40a86d88 |
|
2022-05-27 09:41:40 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a25703f4d644ab4a7572b6bf44d9df78 |
|
2022-05-31 08:40:29 |
LCT Completes Strategic A$1.285M Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0407580df195c912e669763d3404d64d |
|
2022-05-31 08:55:54 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a1c15dbee9800b854d3c499245ef62a |
|
2022-06-03 11:30:30 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68697f769632b6ac97d217f5d62eca5b |
Appendix 2A (Application for Quotation of Securities
|
2022-06-03 14:41:39 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50b076a814dda42182567371f16efeaa |
|
2022-06-06 14:26:24 |
Change of Director's Interest Notice - R Willcocks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b0e00081471a109a0599e7f63997942 |
Change of Director's Interest Notice
|
2022-06-08 12:30:29 |
Change of Director's Interest Notice - C Sue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/723b7d265beb08baf4364e7c10cb9ab3 |
Change of Director's Interest Notice
|
2022-06-21 10:42:41 |
LCT Presenting at Gold Coast Investment Showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdf7bd8e174c5f556f8fea345f6306f0 |
|
2022-06-22 15:26:25 |
NTCELL -Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3442c1662f9028bd0d49aec848bc8b24 |
|
2022-07-19 14:25:08 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cafd23f0ee41d619dbf78a715b2f4815 |
Ceasing to be a substantial holder
|
2022-07-28 10:41:36 |
Change of Director's Interest Notice - B Tuch and A Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3d6f17562b5c7796f1c1e802d04982f |
Change of Director's Interest Notice
|
2022-07-29 09:02:58 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cee9d3af11f2c48f0779f09c2cb77e66 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-08-16 09:31:27 |
NTCELL Update - Choroid plexus tissue shipped to Sydney |
0 |
https://app.sharelinktechnologies.com/announcement/asx/584f6bb5f1185d7faffe616b639c24f3 |
|
2022-08-31 10:02:55 |
Preliminary Final Report and 2022 Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7eb3de5009ed434cf9934a55690d0fde |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-09-05 17:13:12 |
Notification of cessation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5e3b6430b1c55c2ab22dd286a8312c44 |
Appendix 3H (Notification of cessation of securities)
|
2022-09-06 09:32:30 |
Notification regarding unquoted securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfcad53898e4e7f1cf28166fa464a6ed |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-09-09 11:25:23 |
Change of Director's Interest Notice - R Willcocks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29b8bb2b88667052e6a2f661e6395502 |
Change of Director's Interest Notice
|
2022-09-14 11:05:51 |
Receipt of Section 249D Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7faf1d7b0ee0d049defb20d2d2586a7 |
Notice of Meeting - Other
Company Administration - Other
|
2022-09-14 11:42:40 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b1850856193c624d99d20ca3dc9c8fd |
Becoming a substantial holder
|
2022-09-16 13:06:03 |
New milestone for LCT's AI development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80937b5f6dc37d263482f7fd20d6b8aa |
|
2022-09-19 10:29:27 |
2022 Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93df878dc3e6819591026c09a8db09a4 |
Notice of Meeting - Other
|
2022-09-27 16:09:02 |
NEW 2022 Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fba8334b81ec15efc664a859214cff3 |
Notice of Meeting - Other
Company Administration - Other
|
2022-09-30 10:08:05 |
Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/401eb841b40e282edeb34a133e62a5dc |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-09-30 10:08:06 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ebfd9e3fa2426f447730e54650ce973 |
|
2022-09-30 10:32:59 |
2022 Annual General Meeting and Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d97336c62a1b7e9b40114b6786f31e1c |
Notice of Annual General Meeting
|
2022-10-12 15:21:58 |
Chairman Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65c97d9a0e2071c04dd19615ba638305 |
Notice of Meeting - Other
Chairman's Address to Shareholders
|
2022-10-27 12:55:54 |
Online attendance option for 2022 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39ee76bdec72996c542a519cf864e2cc |
Notice of Meeting - Other
|
2022-10-28 14:16:12 |
Quarterly Activity Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0169640cd5c92033244782ed149aaff4 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-10-31 09:21:19 |
Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd3ba950dac47c9d49717392b6001177 |
Director Appointment/Resignation
|
2022-10-31 10:45:44 |
Initial Director's Interest Notice - D Hainsworth |
0 |
https://app.sharelinktechnologies.com/announcement/asx/334ca25c5073e42f9cd056c3fa53baa6 |
Initial Director's Interest Notice
|
2022-10-31 10:46:45 |
Initial Director's Interest Notice - B Dilkes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af472b87d040e52d9a284ff86827bb16 |
Initial Director's Interest Notice
|
2022-10-31 10:47:46 |
Final Director's Interest Notice - R Willcocks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2e656495084f9f8668ed181872dd304 |
Final Director's Interest Notice
|
2022-10-31 10:49:48 |
Final Director's Interest Notice - B Tuch |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88c3cfc73c4929facc1f38099b637464 |
Final Director's Interest Notice
|
2022-10-31 10:50:49 |
Final Director's Interest Notice - A Kelly |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27c1d0b81e19ef40000d808d18656ced |
Initial Director's Interest Notice
|
2022-11-01 10:14:03 |
2022 AGM Update - Withdrawal of Resolutions |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aaa6d3f6c93da17e4ea86fba2f7dae25 |
Notice of Meeting - Other
|
2022-11-04 08:55:52 |
2022 AGM Update - Cancellation of Online Attendance Option |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ada971fd218002e3eb4e530ab110894 |
Alteration to Notice of Meeting
|
2022-11-04 15:08:05 |
AGM Update- Addendum to Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2dd5f34791a3d07c5226c871b862435 |
Notice of Annual General Meeting
|
2022-11-10 17:26:24 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/778baeae586f5c8ec10d3dca7164f0e8 |
|
2022-11-14 17:01:58 |
Amended Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/237d676b64b86011c2d6626637c83a17 |
|
2022-11-24 09:06:57 |
Cessation of OptiCellAI Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b881f0c4253a669b60f4fadbdde4ca6a |
|
2022-12-05 10:17:13 |
Personnel Announcement and Cessation of Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be304325d93ad3134158cfda03c972af |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2022-12-13 12:43:42 |
Notification of cessation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22415b0af3f414d30e2056052e0a8669 |
Appendix 3H (Notification of cessation of securities)
|
2023-01-05 15:00:56 |
Appointment of Executive Chairman - D Hainsworth |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0bd0758735c41e92b16819b93e6564a |
Chairman Appointment/Resignation
|
2023-01-27 08:57:54 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/234bb802ebdbbe5d76de754bb2fab6e4 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-02-27 09:20:18 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c2c1fed0750b766d7bcb159e9404a98 |
|
2023-02-28 07:50:51 |
Half Year Accounts and Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7216a1b0a1dc4df3c459811287baac75 |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-03-01 08:03:35 |
LCT Undertakes $2.5 Million Capital Raise Initiative |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c67dbea6a447de8ee154d1fdefe0028 |
|
2023-03-02 14:35:26 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8043f56f187eaa62772d7a154ad33175 |
|
2023-03-02 15:09:08 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5022ef18bd40f72dfd8773fefe8ef3c6 |
|
2023-03-02 15:21:20 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4eaf06388352d90f43b4270bec64c34 |
|
2023-03-03 18:13:08 |
Update - Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e994b2c4c52befacbef70c3e8ead1a3e |
|
2023-03-06 08:15:00 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dbc04b4819db1f40b3b56920aec348a2 |
Details of Share Registry address
|
2023-03-09 14:48:46 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea28e0db9aca26a5a7ac27cea379b50c |
Appendix 2A (Application for Quotation of Securities
|
2023-03-09 14:51:49 |
Notification regarding unquoted securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/264c9e682a61f4b71933596c0d1e4f00 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-03-09 14:52:51 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7df024dbdddabedae20afcce1ad76c8 |
|
2023-03-10 15:11:09 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c00ea5b30981952a5b4bec77bfab9d97 |
|
2023-03-10 17:32:18 |
APeT Cleansing Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e68fb8c97dca0bbc99040ff9a565dca |
Company Administration - Other
|
2023-03-20 17:39:09 |
Rights Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e61353c8ad3acac3c19b7e33e857f674 |
|
2023-03-20 17:39:13 |
Update - Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1773f8200975b6a144aae0492e4fdbd |
|
2023-04-17 08:16:09 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0ae1de95c6ff29bf522943125d63d77 |
Details of Registered office address
|
2023-04-18 08:44:59 |
Rights Issue Shortfall Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45a6d00e00df33f2b0bb04220ddc54e6 |
|
2023-04-21 10:34:25 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f1a21782dde856d7d5c2495371c0f9b |
Appendix 2A (Application for Quotation of Securities
|
2023-04-21 10:57:27 |
Notification regarding unquoted securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92d32824c267031c65e503a5f4922635 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-04-21 16:38:24 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d2e3acbbf72f0190b80f03c545c1951 |
|
2023-04-27 14:26:05 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67ffebb6c397ee4cac171e3b58a648fe |
Change of Director's Interest Notice
|
2023-04-27 14:26:06 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/273e84b410476ef3d27fa06b09229da1 |
Change of Director's Interest Notice
|
2023-04-28 10:14:08 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/19f58f12c4ff8acd7014d773bc71da52 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-05-03 11:23:18 |
LCT Announces Shortfall Completion Notice |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79682e0fb9bc75f66af9a9e9bbb95ed4 |
|
2023-05-04 13:58:55 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2df25e1be7dfe7535b377822a9eaed8b |
Appendix 2A (Application for Quotation of Securities
|
2023-05-04 13:58:56 |
Notification regarding unquoted securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eec9fb63f7fec9f270bdef2e69235b7f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-05-04 14:08:59 |
CLEANSING STATEMENT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cb1b1cc47f60845834458df99524eea |
|
2023-06-09 08:52:39 |
Appointment of Chief Scientific Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5afeadfb5080043d6b6253ef305ed352 |
Company Administration - Other
|
2023-06-19 09:35:17 |
NTCELL Project Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c9b21c92d4058d99474d301636852e04 |
|
2023-06-22 08:15:36 |
Notice of initial substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3b90b3b687f0c1e7c7a370b8e9597e9 |
Becoming a substantial holder
|
2023-07-03 08:31:25 |
Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fee0632c9e49f1f209b843921ba3db59 |
Director Appointment/Resignation
Company Secretary Appointment/Resignation
|
2023-07-05 15:30:29 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be2e35195200721bff91b0be319a2def |
Final Director's Interest Notice
|
2023-07-05 15:31:30 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0eee1c729aaa7a033c0905f840c6d8a2 |
Initial Director's Interest Notice
|
2023-07-07 15:30:29 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3cdb214eef94098df5bd0982edc5c444 |
|
2023-07-07 15:32:31 |
Proposed issue of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abdaac31fbd0c354a7e2ed873304d89c |
|
2023-07-11 08:15:11 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ec8115895b713ce6bf742eeee1a1864 |
Appendix 2A (Application for Quotation of Securities
|
2023-07-11 08:16:20 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15781c60baf5880b87b556f50df6bca9 |
Appendix 2A (Application for Quotation of Securities
|
2023-07-11 08:16:26 |
Notification regarding unquoted securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43eb0fe1ee4d7639fe5b46a9ca5202c7 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-07-11 09:02:57 |
Name and Branding Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ab9338fca8dacf6a09be58a3645ae4d |
Notice of Meeting - Other
Company Administration - Other
|
2023-07-26 08:29:24 |
Patent application over AI-116 for Dementia filed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/027ae5df1dc54e13641bf8b2302f1293 |
|
2023-07-28 08:14:04 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cc518690a110ccb7bbeef034eaa2b7d |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-07-28 15:44:42 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea6c13bff3fde3d716cb3f09ca29b8b9 |
Notice of General Meeting
|
2023-08-22 15:36:35 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7799de541d2002cee73b1361ce497057 |
Appendix 2A (Application for Quotation of Securities
|
2023-08-22 15:38:37 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b84ab3d576a31548fcb8ab98e7df508 |
|
2023-08-30 17:54:49 |
Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/367f934ade232c323b610b76a23f55d3 |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-09-01 08:07:38 |
LCT commences AI-116 pre clinical studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/34ea7e62f1acfd8468b0a6c3a97c337e |
|
2023-09-01 13:18:16 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b1d4ea86c66c1df7519b17a54e7499c |
|
2023-09-05 15:33:32 |
LCT Global Announces Staffing Adjustment for NTCELL Project |
0 |
https://app.sharelinktechnologies.com/announcement/asx/606bc1cffecf44a7ce3ffaf73e78b6f0 |
Company Administration - Other
|
2023-09-08 11:01:54 |
Company name and stock code change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8d6c1d4a0c3ba2dc4c7d1cdc44c433c |
Company Administration - Other
|
2023-09-08 15:56:56 |
Application for quotation of securities - LCT |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63708060a2d6455c04cdb11d209b8a9f |
Appendix 2A (Application for Quotation of Securities
|
2023-09-08 15:58:57 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49195af7516c1361dce27322eac63670 |
|
2023-09-11 08:23:07 |
MOU with UNSW to develop AI Platform |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88998783ef8499fd92fa91d203ae4536 |
|
2023-09-12 08:20:05 |
2023 Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ca8932c9745d480d5952d4496654491 |
Notice of Meeting - Other
Company Administration - Other
|
2023-09-12 08:43:41 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af62b30d5ecde2fa5be3be35f8646e45 |
|
2023-09-28 09:00:56 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73766edd48b6acced80c0d1520330933 |
Notice of Annual General Meeting
|
2023-10-16 17:50:49 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5a1017199cb11d82c082d8ce13201ac |
|
2023-10-16 17:52:51 |
Change of Director's Interest Notice x2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c9ad9ca23763e26a961ef862b6f4ad9 |
Change of Director's Interest Notice
|
2023-10-17 13:43:42 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8d15c6e1a3ae95c6df83844fc416585 |
|
2023-10-24 15:54:53 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9456537aa3a9ad690d43639de65e9a14 |
|
2023-10-25 09:24:21 |
1AI develops Artificial Intelligence Platform |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6d78738c42bd4c800af2d0afc29bfde |
|
2023-10-27 08:05:22 |
Quarterly Activities/Appendix 5B Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33fa0334c32b2c4f7667f4d0cadd88d6 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-10-31 09:27:24 |
CSIRO Grant for Artificial Intelligence Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/87cf3c6306740de79c7ce6f17445d261 |
|
2023-11-02 09:43:40 |
AGM Chairman Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8635e99ff0e8203b7901983d936cbd3d |
Chairman's Address to Shareholders
|
2023-11-02 14:10:09 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c23a2c181721e202dfa7dfe670fe2062 |
|
2023-11-07 16:27:26 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b97d05fd9dff0c343577af920f523f0a |
|
2023-11-08 15:52:51 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0405a080284b34d34035c265d5073aa6 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-08 17:46:43 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb06e061a739e592d6030ff40e837318 |
|
2023-11-08 17:54:53 |
Notification regarding unquoted securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00bc90943efa12e088b9af0df562fb64 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-11-08 18:01:57 |
Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce43f9b3879e295e04c07f2c47c5cf5e |
|
2023-11-10 15:01:57 |
Appendix 3y and Amended Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec4e0aaafe6c24562cd01ff48e12caf1 |
Change of Director's Interest Notice
|
2023-11-10 15:04:03 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89e4a62e5dcb92cb1a7da08a767f467d |
Appendix 2A (Application for Quotation of Securities
|
2023-11-10 15:07:04 |
Appendix 3Y x 3 and Cleansing Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8595f80627482cc3e1563b184e3add95 |
Change of Director's Interest Notice
|
2023-11-21 15:31:27 |
Addendum to September Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d785d9d0f7e7ff17d3688066fc5e9fd6 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-11-23 09:07:05 |
1AI commences AI-168 pre-clinical studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/afc98edc7842327e73593b1ed53f486b |
|
2023-12-05 15:56:40 |
Algorae to list existing Option series on ASX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6d061d9f6f038e11dfeb82172e27c69 |
|
2023-12-05 16:02:01 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/271ee802d01bbf77f86e4d9204bba4c5 |
|
2023-12-05 16:03:02 |
Notification regarding unquoted securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb227c425c55c7f2ddd34057468851f6 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-06 14:55:53 |
Notification regarding unquoted securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a0f312fe632ae2ab3cf378f4957cbbc |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-06 15:35:34 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/02db25084440c88dde061f0af4cd80db |
Appendix 2A (Application for Quotation of Securities
|
2023-12-06 15:38:37 |
Cleansing Statement with Distribution and Top 20 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac7a4448e2d5a2d1e19d88501d28e816 |
|
2023-12-28 09:30:24 |
Agreement with HL Pharma |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a3736bf10e8de3c842ca5878933ae6b |
|
2023-12-28 16:51:50 |
Notification regarding unquoted securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/674fd6286ebf8e90efdf56a8b6f8178a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-28 17:02:59 |
Cleansing Statement and 3x Appendix 3Ys |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13874cfc94da2362d3e53e15ef904bb2 |
Change of Director's Interest Notice
|
2024-01-05 08:24:23 |
Notification of cessation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1e9ba9ef1eebc238be974c11f074dc1 |
Appendix 3H (Notification of cessation of securities)
|
2024-01-05 08:45:43 |
Agreement with HL Pharma Addendum |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89eae54a72990211c1d077ae207ec3ae |
|
2024-01-17 12:57:55 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6688a5b504c1349db3f7888300dc30ba |
Company Secretary Appointment/Resignation
|
2024-01-30 09:29:27 |
Quarterly Activities Report/Appendix 4C Cash Flow Statement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/822322f238d5a49021fd9cf652195f01 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-02-02 14:25:23 |
Details of Auditor Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fc63509b09de054c82d18da76fa71dd |
Details of Auditor Appointment/Resignation
|
2024-02-14 15:15:13 |
NTCELL Project Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f1dede5ac3898b64c6a7d30615eaa28 |
|
2024-02-20 16:32:23 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30236f6711956f6d4f28b2aece05c651 |
|
2024-02-22 15:28:26 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f8653cc9c8ed38f0db9e32f7ec4836b |
Notice of General Meeting
|
2024-02-22 15:29:03 |
Listing Rule Breach and Remediation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/530aa98938b5e2c969566cd5cd0f0fc9 |
Company Administration - Other
|
2024-02-28 15:25:23 |
Appendix 3Y x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/865c2c61f59e93251a0d80ecfc9dfec3 |
Change of Director's Interest Notice
|
2024-02-28 15:26:25 |
Notification of cessation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a30dc342a5caa0682783ffa6e8178d5a |
Appendix 3H (Notification of cessation of securities)
|
2024-02-29 09:37:34 |
Half Yearly Report and Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bcb45cddfb21bfd518c57b0bf5cc034d |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-02-29 09:37:35 |
Half Yearly Report Announcement and Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05971be93de6df7b2400e52f70cac2c8 |
|
2024-03-08 08:47:44 |
Artificial Intelligence Platform Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e70b6ab3907f02a09fbfe61ec56ca1ba |
|
2024-03-08 10:03:02 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/116e9d9d17788154d3929c3e0106d17b |
Appendix 2A (Application for Quotation of Securities
|
2024-03-08 10:15:14 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06188ba08e0c6ce692de8f1216e6b7ed |
|
2024-03-20 16:16:15 |
Upcoming Expiry Of 1AIOA Quoted Option Series |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3c10ba233316fb9c5e604c89e6c2421 |
|
2024-03-26 15:11:10 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef5873d4d14824a8dc832acecfb86a8c |
|
2024-04-08 09:28:27 |
Positive results from AI-116 in vitro studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9beadf96333d62adccbcfc745bbfa546 |
|
2024-04-18 09:07:06 |
1AI Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51a9aca0626039cb95358abdc43f0e0a |
|
2024-04-22 16:19:18 |
Notification of cessation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b792aa82e7704229e2e017495d0f7ccb |
Appendix 3H (Notification of cessation of securities)
|
2024-04-22 16:21:20 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d3510428a3f090f5d9f8d7ec9a928cb |
Appendix 2A (Application for Quotation of Securities
|
2024-04-23 16:38:37 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3494e4e277350a7f554c1ae287a44df6 |
|
2024-04-26 16:33:32 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/232ab0c59e8321e45ad9669d3bdc529a |
Appendix 2A (Application for Quotation of Securities
|
2024-04-29 08:41:39 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00f66d7a1da01e24a1ffa84539174fb8 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-04-30 18:05:04 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c4496424d46776e8c49c198c5b68977 |
Appendix 2A (Application for Quotation of Securities
|
2024-04-30 18:08:06 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/513fb4b455868c85cc5c2f809ab839a6 |
|
2024-05-09 10:00:58 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01219e71fd631ea31506f364131dd591 |
Company Secretary Appointment/Resignation
|
2024-05-16 16:07:06 |
Application for quotation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9eb70766ab7b6d9aac3d427f777f77cb |
Appendix 2A (Application for Quotation of Securities
|
2024-05-16 16:12:11 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbfccc46f9e7e168400fdd5c4c151546 |
|
2024-07-01 18:06:03 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fe8522f85b0f6e6a7158568dd1ae071 |
Company Secretary Appointment/Resignation
|
2024-07-22 09:15:14 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9daee07cd548fdc21898babd0751248b |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-07-31 08:59:57 |
Positive results from AI-116 in vitro studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e2d30dd27fd11ff9de515c3b147d456 |
|
2024-08-30 17:40:38 |
Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ac03b26c99742fa15a145ffbc6a44d7 |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-08-30 17:47:45 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/849922f4489329c2e425af1de5286d2f |
|
2024-09-02 18:03:01 |
Notification of cessation of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bf369dc1860f945aee7e5e17ebfd0da |
Appendix 3H (Notification of cessation of securities)
|
2024-09-06 16:27:26 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/278cf3e73dc754c30836d8a7c0071604 |
Notice of Meeting - Other
Company Administration - Other
|
2024-09-23 17:08:07 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6b9c976e54bda825b538a7fc5484bf1 |
Notice of Annual General Meeting
|
2024-09-24 09:01:59 |
AlgoraeOS Artificial Intelligence Platform Launched |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb615859694fae66b06dbb6ab1f2aa08 |
|
2024-10-23 08:52:49 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e30823a507ebaaaf9bced0dc8d58843 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2024-10-25 09:05:00 |
AGM Chairman Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba8feee6b80ca7494f24023a43ce8a21 |
Chairman's Address to Shareholders
|
2024-10-25 15:43:42 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b08f4b2aad7d0c1c4285154c4f3c580 |
|
2024-10-25 15:48:47 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/423d34069eccbdd90dc6598ab2cc0ea3 |
|
2024-10-28 18:09:06 |
Notification regarding unquoted securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/406a875135b9a9067b42ecfd3d571b89 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-10-28 18:23:23 |
Appendix 3Y x2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6ed22255a1a5bbc47b836cd05bc558b |
Change of Director's Interest Notice
|
2024-11-18 09:02:59 |
Algorae Discontinues Legacy OTCQB AD Share Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec1385602ff9c3df6bf1144d2b8bdd0f |
Company Administration - Other
|
2024-11-18 09:09:08 |
Proposed issue of securities - 1AI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3230c8255305dd156479860b986dc2f3 |
|
2024-11-21 09:08:07 |
24 New AI-Generated Drug Targets |
1 |
https://app.sharelinktechnologies.com/announcement/asx/adde40ad7e9603f587c187241302bb0f |
|
2024-11-28 08:56:55 |
Appointment of Pharmaceutical Executive |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6e7097a737d0264938bf5bf33a4f79d |
|
2024-11-29 08:59:55 |
Significant Cardioprotection Qualities in AI-168 Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50b0679e4f2d42351f5b7a05b358eef0 |
|